{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 6,
   "outputs": [],
   "source": [
    "import pandas\n",
    "from reactome2py import analysis, content, fiviz\n",
    "from collections import defaultdict\n",
    "from itertools import chain\n",
    "from operator import methodcaller"
   ],
   "metadata": {
    "collapsed": false,
    "pycharm": {
     "name": "#%%\n"
    }
   }
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Assessing pathways and drug targets in Cyclic Multiplexed-Immunofluorescence (cmIF) image biomarkers\n",
    "Resource: https://www.ncbi.nlm.nih.gov/pubmed/31502168\n",
    "\n",
    "1. After mapping proteins to gene names, we wrangle the matrix into a dictionary where each image section would hold the biomarkers as its values. "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "path = \"data/marker_matrix_gene.csv\"\n",
    "\n",
    "df = pandas.read_csv(path, index_col=0)\n",
    "df = df.apply(lambda x : x.str.split(\",\"), axis=0)\n",
    "row_dict = df.T.to_dict('records')\n",
    "\n",
    "def imggenes2dict(row_dict):\n",
    "    dd = defaultdict(list)\n",
    "    dict_items = map(methodcaller('items'), row_dict)\n",
    "    \n",
    "    for k, v in chain.from_iterable(dict_items):\n",
    "        dd[k].extend(v)\n",
    "    \n",
    "    img_dict = dict(dd)\n",
    "    return(img_dict)\n",
    "\n",
    "img_dict = imggenes2dict(row_dict)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "2. Now we can pass the biomarkers to fetch all possible reactome pathways available for each image segment. "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'R1': ['MS4A1', 'CD8A', 'CD4', 'KRT19'], 'R2': ['PCNA', 'CD68', 'PDCD1', 'PTRPC'], 'R3': ['KRT8', 'HER2', 'FOXP3', 'KRT5'], 'R4': ['H3F3A', 'H3F3B', 'RPS6', 'ESR1', 'CD44'], 'R5': ['KRT17', 'PDPN', 'PECAM1', 'GZMB'], 'R6': ['VIM', 'pAb', 'RB1', 'CD3'], 'R7': ['ACTA2', 'PARP1', 'H2AFX', 'CDH1'], 'R8': ['KRT7', 'KRT14', 'COL4A1', 'LMNA'], 'R9': ['H3K27', 'CD274', 'MKI67', 'PGR'], 'R10': ['LMNB1', 'H3K4', 'LMNB2', 'COL1A1'], 'R11': ['CD34', 'AR', 'HIF1A', 'FOXP3'], 'R12': ['AKT1', 'BMP2', 'BMP4', 'MAPK1 ', 'MAPK3'], 'R13': ['BRD4', 'CASP3', 'NCAM1', 'MTOR']}\n"
     ]
    }
   ],
   "source": [
    "print(img_dict)"
   ],
   "metadata": {
    "collapsed": false,
    "pycharm": {
     "name": "#%%\n"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [],
   "source": [
    "result = [analysis.identifiers(ids=\",\".join(d)) for d in img_dict.values()]\n",
    "tokens = [r['summary']['token'] for r in result]\n",
    "\n",
    "\n",
    "def get_pathways(t):\n",
    "    token_result = analysis.token(token=t, species='Homo sapiens', page_size='-1', page='-1', sort_by='ENTITIES_FDR', \n",
    "                                  order='ASC', resource='TOTAL', p_value='1', include_disease=True, \n",
    "                                  min_entities=None, max_entities=None)\n",
    "    l = [p['name'] for p in token_result['pathways']]\n",
    "    l.sort() \n",
    "    return(l)\n",
    "\n",
    "pathways = [get_pathways(t) for t in tokens]"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "3. Given the biomarkers, we can also fetch all available drug targets from Drug Central."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[['Adaptive Immune System', 'Alpha-defensins', 'Antimicrobial peptides', 'Binding and entry of HIV virion', 'Cargo recognition for clathrin-mediated endocytosis', 'Clathrin-mediated endocytosis', 'Costimulation by the CD28 family', 'Cytokine Signaling in Immune system', 'Defensins', 'Developmental Biology', 'Disease', 'Downstream TCR signaling', 'Early Phase of HIV Life Cycle', 'Formation of the cornified envelope', 'Generation of second messenger molecules', 'HIV Infection', 'HIV Life Cycle', 'Host Interactions of HIV factors', 'Immune System', 'Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'Infectious disease', 'Innate Immune System', 'Keratinization', 'Membrane Trafficking', 'Nef Mediated CD4 Down-regulation', 'Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters', 'Other interleukin signaling', 'PD-1 signaling', 'Phosphorylation of CD3 and TCR zeta chains', 'Signaling by Interleukins', 'TCR signaling', 'The role of Nef in HIV-1 replication and disease pathogenesis', 'Translocation of ZAP-70 to Immunological synapse', 'Vesicle-mediated transport', 'Vpu mediated degradation of CD4'], ['Adaptive Immune System', 'Base Excision Repair', 'Cell Cycle', 'Cell Cycle, Mitotic', 'Chromosome Maintenance', 'Costimulation by the CD28 family', 'DNA Damage Bypass', 'DNA Double-Strand Break Repair', 'DNA Repair', 'DNA Replication', 'DNA strand elongation', 'Disease', 'Dual Incision in GG-NER', 'Dual incision in TC-NER', 'E3 ubiquitin ligases ubiquitinate target proteins', 'Extension of Telomeres', 'G0 and Early G1', 'G1/S Transition', 'G1/S-Specific Transcription', 'Gap-filling DNA repair synthesis and ligation in GG-NER', 'Gap-filling DNA repair synthesis and ligation in TC-NER', 'Gene expression (Transcription)', 'Generic Transcription Pathway', 'Global Genome Nucleotide Excision Repair (GG-NER)', 'HDR through Homologous Recombination (HRR)', 'HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)', 'Homology Directed Repair', 'Immune System', 'Infectious disease', 'Innate Immune System', 'Lagging Strand Synthesis', 'Leading Strand Synthesis', 'Metabolism of proteins', 'Mismatch Repair', 'Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)', 'Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)', 'Mitotic G1 phase and G1/S transition', 'Neutrophil degranulation', 'Nucleotide Excision Repair', 'PCNA-Dependent Long Patch Base Excision Repair', 'PD-1 signaling', 'Polymerase switching', 'Polymerase switching on the C-strand of the telomere', 'Post-translational protein modification', 'Potential therapeutics for SARS', 'Processive synthesis on the C-strand of the telomere', 'Processive synthesis on the lagging strand', 'Protein ubiquitination', 'RNA Polymerase II Transcription', 'Recognition of DNA damage by PCNA-containing replication complex', 'Removal of the Flap Intermediate', 'Removal of the Flap Intermediate from the C-strand', 'Resolution of AP sites via the multiple-nucleotide patch replacement pathway', 'Resolution of Abasic Sites (AP sites)', 'S Phase', 'SARS-CoV Infections', 'SUMO E3 ligases SUMOylate target proteins', 'SUMOylation', 'SUMOylation of DNA replication proteins', 'Synthesis of DNA', 'TP53 Regulates Transcription of Cell Cycle Genes', 'TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest', 'Telomere C-strand (Lagging Strand) Synthesis', 'Telomere Maintenance', 'Termination of translesion DNA synthesis', 'Transcription of E2F targets under negative control by DREAM complex', 'Transcription-Coupled Nucleotide Excision Repair (TC-NER)', 'Transcriptional Regulation by TP53', 'Translesion Synthesis by POLH', 'Translesion synthesis by POLI', 'Translesion synthesis by POLK', 'Translesion synthesis by REV1', 'Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template'], ['Axon guidance', 'Cell junction organization', 'Cell-Cell communication', 'Constitutive Signaling by Aberrant PI3K in Cancer', 'Constitutive Signaling by Overexpressed ERBB2', 'Developmental Biology', 'Disease', 'Diseases of signal transduction by growth factor receptors and second messengers', 'Downregulation of ERBB2 signaling', 'Downregulation of ERBB2:ERBB3 signaling', 'Drug resistance in ERBB2 KD mutants', 'Drug resistance in ERBB2 TMD/JMD mutants', 'Drug-mediated inhibition of ERBB2 signaling', 'ERBB2 Activates PTK6 Signaling', 'ERBB2 Regulates Cell Motility', 'Formation of the cornified envelope', 'GRB2 events in ERBB2 signaling', 'GRB7 events in ERBB2 signaling', 'Gene expression (Transcription)', 'Generic Transcription Pathway', 'Intracellular signaling by second messengers', 'Keratinization', 'MAPK family signaling cascades', 'MAPK1/MAPK3 signaling', 'Negative regulation of the PI3K/AKT network', 'Nervous system development', 'PI3K events in ERBB2 signaling', 'PI3K/AKT Signaling in Cancer', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling', 'PIP3 activates AKT signaling', 'PLCG1 events in ERBB2 signaling', 'RAF/MAP kinase cascade', 'RNA Polymerase II Transcription', 'RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs)', 'RUNX1 regulates transcription of genes involved in WNT signaling', 'Resistance of ERBB2 KD mutants to AEE788', 'Resistance of ERBB2 KD mutants to afatinib', 'Resistance of ERBB2 KD mutants to lapatinib', 'Resistance of ERBB2 KD mutants to neratinib', 'Resistance of ERBB2 KD mutants to osimertinib', 'Resistance of ERBB2 KD mutants to sapitinib', 'Resistance of ERBB2 KD mutants to tesevatinib', 'Resistance of ERBB2 KD mutants to trastuzumab', 'SHC1 events in ERBB2 signaling', 'Sema4D in semaphorin signaling', 'Sema4D induced cell migration and growth-cone collapse', 'Semaphorin interactions', 'Signal Transduction', 'Signaling by ERBB2', 'Signaling by ERBB2 ECD mutants', 'Signaling by ERBB2 KD Mutants', 'Signaling by ERBB2 TMD/JMD mutants', 'Signaling by ERBB2 in Cancer', 'Signaling by Non-Receptor Tyrosine Kinases', 'Signaling by PTK6', 'Signaling by Receptor Tyrosine Kinases', 'TFAP2 (AP-2) family regulates transcription of growth factors and their receptors', 'Transcriptional regulation by RUNX1', 'Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors', 'Type I hemidesmosome assembly'], ['Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3', 'Activation of HOX genes during differentiation', 'Activation of anterior HOX genes in hindbrain development during early embryogenesis', 'Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S', 'Amyloid fiber formation', 'Assembly of the ORC complex at the origin of replication', 'Assembly of the pre-replicative complex', 'Axon guidance', 'B-WICH complex positively regulates rRNA expression', 'Cap-dependent Translation Initiation', 'Cell Cycle', 'Cell Cycle, Mitotic', 'Cell surface interactions at the vascular wall', 'Cellular Senescence', 'Cellular response to starvation', 'Cellular responses to stimuli', 'Cellular responses to stress', 'Chromosome Maintenance', 'Condensation of Prophase Chromosomes', 'Constitutive Signaling by Aberrant PI3K in Cancer', 'Cytokine Signaling in Immune system', 'DNA Replication', 'DNA Replication Pre-Initiation', 'DNA methylation', 'Defective pyroptosis', 'Degradation of the extracellular matrix', 'Deubiquitination', 'Developmental Biology', 'Disease', 'Diseases of programmed cell death', 'Diseases of signal transduction by growth factor receptors and second messengers', 'ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression', 'ESR-mediated signaling', 'Epigenetic regulation of gene expression', 'Estrogen-dependent gene expression', 'Eukaryotic Translation Elongation', 'Eukaryotic Translation Initiation', 'Eukaryotic Translation Termination', 'Extra-nuclear estrogen signaling', 'Extracellular matrix organization', 'Factors involved in megakaryocyte development and platelet production', 'Formation of a pool of free 40S subunits', 'Formation of the beta-catenin:TCF transactivating complex', 'Formation of the ternary complex, and subsequently, the 43S complex', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Gene Silencing by RNA', 'Gene expression (Transcription)', 'Generic Transcription Pathway', 'Glycosaminoglycan metabolism', 'Hemostasis', 'Hyaluronan metabolism', 'Hyaluronan uptake and degradation', 'Immune System', 'Infectious disease', 'Influenza Infection', 'Influenza Viral RNA Transcription and Replication', 'Inhibition of DNA recombination at telomere', 'Innate Immune System', 'Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA', 'Integrin cell surface interactions', 'Interferon Signaling', 'Interferon gamma signaling', 'Intracellular signaling by second messengers', 'L13a-mediated translational silencing of Ceruloplasmin expression', 'M Phase', 'MTOR signalling', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'Meiosis', 'Meiotic recombination', 'Metabolism', 'Metabolism of RNA', 'Metabolism of amino acids and derivatives', 'Metabolism of carbohydrates', 'Metabolism of proteins', 'Mitotic Prophase', 'Negative epigenetic regulation of rRNA expression', 'Negative regulation of the PI3K/AKT network', 'Nervous system development', 'Neutrophil degranulation', 'NoRC negatively regulates rRNA expression', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense-Mediated Decay (NMD)', 'Nuclear Receptor transcription pathway', 'Nuclear events stimulated by ALK signaling in cancer', 'Nuclear signaling by ERBB4', 'Ovarian tumor domain proteases', 'Oxidative Stress Induced Senescence', 'PI3K/AKT Signaling in Cancer', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling', 'PIP3 activates AKT signaling', 'PRC2 methylates histones and DNA', 'Peptide chain elongation', 'Positive epigenetic regulation of rRNA expression', 'Post-translational protein modification', 'Pre-NOTCH Expression and Processing', 'Pre-NOTCH Transcription and Translation', 'RHO GTPase Effectors', 'RHO GTPases activate PKNs', 'RNA Polymerase I Promoter Clearance', 'RNA Polymerase I Promoter Escape', 'RNA Polymerase I Promoter Opening', 'RNA Polymerase I Transcription', 'RNA Polymerase II Transcription', 'RUNX1 regulates estrogen receptor mediated transcription', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function', 'RUNX1 regulates transcription of genes involved in WNT signaling', 'RUNX1 regulates transcription of genes involved in differentiation of HSCs', 'Regulation of RUNX2 expression and activity', 'Regulation of expression of SLITs and ROBOs', 'Reproduction', 'Response of EIF2AK4 (GCN2) to amino acid deficiency', 'Ribosomal scanning and start codon recognition', 'SIRT1 negatively regulates rRNA expression', 'SRP-dependent cotranslational protein targeting to membrane', 'SUMO E3 ligases SUMOylate target proteins', 'SUMOylation', 'SUMOylation of intracellular receptors', 'Selenoamino acid metabolism', 'Selenocysteine synthesis', 'Senescence-Associated Secretory Phenotype (SASP)', 'Signal Transduction', 'Signaling by ALK fusions and activated point mutants', 'Signaling by ALK in cancer', 'Signaling by ERBB4', 'Signaling by NOTCH', 'Signaling by Nuclear Receptors', 'Signaling by ROBO receptors', 'Signaling by Receptor Tyrosine Kinases', 'Signaling by Rho GTPases', 'Signaling by Rho GTPases, Miro GTPases and RHOBTB3', 'Signaling by WNT', 'TCF dependent signaling in response to WNT', 'TFAP2 (AP-2) family regulates transcription of growth factors and their receptors', 'Telomere Maintenance', 'Transcriptional regulation by RUNX1', 'Transcriptional regulation by RUNX2', 'Transcriptional regulation by small RNAs', 'Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors', 'Transcriptional regulation of granulopoiesis', 'Translation', 'Translation initiation complex formation', 'Viral mRNA Translation', 'mTORC1-mediated signalling', 'rRNA modification in the nucleus and cytosol', 'rRNA processing', 'rRNA processing in the nucleus and cytosol'], ['Activation, myristolyation of BID and translocation to mitochondria', 'Apoptosis', 'Cell surface interactions at the vascular wall', 'Developmental Biology', 'Extracellular matrix organization', 'Formation of the cornified envelope', 'GPVI-mediated activation cascade', 'Hemostasis', 'Immune System', 'Innate Immune System', 'Integrin cell surface interactions', 'Intrinsic Pathway for Apoptosis', 'Keratinization', 'NOTCH2 intracellular domain regulates transcription', 'Neutrophil degranulation', 'PECAM1 interactions', 'Platelet activation, signaling and aggregation', 'Platelet degranulation ', 'Platelet homeostasis', 'Platelet sensitization by LDL', 'Programmed Cell Death', 'Pyroptosis', 'Regulated Necrosis', 'Response to elevated platelet cytosolic Ca2+', 'Signal Transduction', 'Signaling by NOTCH', 'Signaling by NOTCH2'], ['APC/C-mediated degradation of cell cycle proteins', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects', 'Aberrant regulation of mitotic cell cycle due to RB1 defects', 'Aberrant regulation of mitotic exit in cancer due to RB1 defects', 'Aggrephagy', 'Apoptosis', 'Apoptotic cleavage of cellular proteins', 'Apoptotic execution phase', 'Autophagy', 'Caspase-mediated cleavage of cytoskeletal proteins', 'Cell Cycle', 'Cell Cycle, Mitotic', 'Cellular Senescence', 'Cellular responses to stimuli', 'Cellular responses to stress', 'Chaperone Mediated Autophagy', 'Condensation of Prophase Chromosomes', 'Cyclin A:Cdk2-associated events at S phase entry', 'Cyclin D associated events in G1', 'Cyclin E associated events during G1/S transition ', 'Cytokine Signaling in Immune system', 'DNA Damage/Telomere Stress Induced Senescence', 'Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)', 'Defective translocation of RB1 mutants to the nucleus', 'Disease', 'Diseases of mitotic cell cycle', 'E2F mediated regulation of DNA replication', 'Formation of Senescence-Associated Heterochromatin Foci (SAHF)', 'G1 Phase', 'G1/S Transition', 'Gene expression (Transcription)', 'Generic Transcription Pathway', 'Immune System', 'Infectious disease', 'Inhibition of replication initiation of damaged DNA by RB1/E2F1', 'Interleukin-4 and Interleukin-13 signaling', 'Late endosomal microautophagy', 'M Phase', 'Macroautophagy', 'Mitotic G1 phase and G1/S transition', 'Mitotic Prophase', 'Muscle contraction', 'Oncogene Induced Senescence', 'Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes', 'Programmed Cell Death', 'RHO GTPase cycle', 'RHOBTB GTPase Cycle', 'RHOBTB1 GTPase cycle', 'RNA Polymerase II Transcription', 'RUNX2 regulates bone development', 'RUNX2 regulates osteoblast differentiation', 'Regulation of mitotic cell cycle', 'Replication of the SARS-CoV-1 genome', 'Replication of the SARS-CoV-2 genome', 'S Phase', 'SARS-CoV Infections', 'SARS-CoV-1 Genome Replication and Transcription', 'SARS-CoV-1 Infection', 'SARS-CoV-2 Genome Replication and Transcription', 'SARS-CoV-2 Infection', 'Selective autophagy', 'Signal Transduction', 'Signaling by Interleukins', 'Signaling by Rho GTPases', 'Signaling by Rho GTPases, Miro GTPases and RHOBTB3', 'Striated Muscle Contraction', 'Transcriptional regulation by RUNX2'], ['APC/C-mediated degradation of cell cycle proteins', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Aberrant regulation of mitotic cell cycle due to RB1 defects', 'Aberrant regulation of mitotic exit in cancer due to RB1 defects', 'Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3', 'Activation of HOX genes during differentiation', 'Activation of anterior HOX genes in hindbrain development during early embryogenesis', 'Adaptive Immune System', 'Adherens junctions interactions', 'Amyloid fiber formation', 'Antigen processing: Ubiquitination & Proteasome degradation', 'Apoptosis', 'Apoptotic cleavage of cell adhesion  proteins', 'Apoptotic cleavage of cellular proteins', 'Apoptotic execution phase', 'Assembly of the ORC complex at the origin of replication', 'Assembly of the pre-replicative complex', 'Autodegradation of Cdh1 by Cdh1:APC/C', 'B-WICH complex positively regulates rRNA expression', 'Base Excision Repair', 'Base-Excision Repair, AP Site Formation', 'CDK-mediated phosphorylation and removal of Cdc6', 'Cell Cycle', 'Cell Cycle Checkpoints', 'Cell Cycle, Mitotic', 'Cell junction organization', 'Cell-Cell communication', 'Cell-cell junction organization', 'Cellular Senescence', 'Cellular responses to stimuli', 'Cellular responses to stress', 'Chromatin modifying enzymes', 'Chromatin organization', 'Chromosome Maintenance', 'Class I MHC mediated antigen processing & presentation', 'Cleavage of the damaged purine', 'Cleavage of the damaged pyrimidine ', 'Condensation of Prophase Chromosomes', 'Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase', 'Cyclin A:Cdk2-associated events at S phase entry', 'DNA Damage Recognition in GG-NER', 'DNA Damage/Telomere Stress Induced Senescence', 'DNA Double Strand Break Response', 'DNA Double-Strand Break Repair', 'DNA Repair', 'DNA Replication', 'DNA Replication Pre-Initiation', 'DNA methylation', 'Defective pyroptosis', 'Degradation of the extracellular matrix', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'Depurination', 'Depyrimidination', 'Developmental Biology', 'Disease', 'Diseases of mitotic cell cycle', 'Diseases of programmed cell death', 'Downregulation of SMAD2/3:SMAD4 transcriptional activity', 'Dual Incision in GG-NER', 'ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression', 'ESR-mediated signaling', 'Epigenetic regulation of gene expression', 'Estrogen-dependent gene expression', 'Extracellular matrix organization', 'Formation of Incision Complex in GG-NER', 'Formation of the beta-catenin:TCF transactivating complex', 'G2/M Checkpoints', 'G2/M DNA damage checkpoint', 'Gene Silencing by RNA', 'Gene expression (Transcription)', 'Generic Transcription Pathway', 'Global Genome Nucleotide Excision Repair (GG-NER)', 'HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)', 'HDR through MMEJ (alt-NHEJ)', 'Homology Directed Repair', 'Immune System', 'Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'Infectious disease', 'Influenza Infection', 'Influenza Viral RNA Transcription and Replication', 'Inhibition of DNA recombination at telomere', 'InlA-mediated entry of Listeria monocytogenes into host cells', 'Integrin cell surface interactions', 'Listeria monocytogenes entry into host cells', 'M Phase', 'Meiosis', 'Meiotic recombination', 'Meiotic synapsis', 'Metabolism of proteins', 'Mitotic Prophase', 'Muscle contraction', 'NOTCH4 Intracellular Domain Regulates Transcription', 'Negative epigenetic regulation of rRNA expression', 'NoRC negatively regulates rRNA expression', 'Nonhomologous End-Joining (NHEJ)', 'Nucleosome assembly', 'Nucleotide Excision Repair', 'Oxidative Stress Induced Senescence', 'POLB-Dependent Long Patch Base Excision Repair', 'PRC2 methylates histones and DNA', 'Packaging Of Telomere Ends', 'Phosphorylation of Emi1', 'Positive epigenetic regulation of rRNA expression', 'Post-translational protein modification', 'Pre-NOTCH Expression and Processing', 'Pre-NOTCH Transcription and Translation', 'Processing of DNA double-strand break ends', 'Programmed Cell Death', 'RHO GTPase Effectors', 'RHO GTPases activate IQGAPs', 'RHO GTPases activate PKNs', 'RMTs methylate histone arginines', 'RNA Polymerase I Promoter Clearance', 'RNA Polymerase I Promoter Escape', 'RNA Polymerase I Promoter Opening', 'RNA Polymerase I Transcription', 'RNA Polymerase II Transcription', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function', 'RUNX1 regulates transcription of genes involved in differentiation of HSCs', 'Recognition and association of DNA glycosylase with site containing an affected purine', 'Recognition and association of DNA glycosylase with site containing an affected pyrimidine', 'Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks', 'Regulation of APC/C activators between G1/S and early anaphase', 'Regulation of mitotic cell cycle', 'Reproduction', 'Resolution of AP sites via the multiple-nucleotide patch replacement pathway', 'Resolution of Abasic Sites (AP sites)', 'S Phase', 'SCF-beta-TrCP mediated degradation of Emi1', 'SIRT1 negatively regulates rRNA expression', 'SUMO E3 ligases SUMOylate target proteins', 'SUMOylation', 'SUMOylation of DNA damage response and repair proteins', 'Senescence-Associated Secretory Phenotype (SASP)', 'Signal Transduction', 'Signaling by NOTCH', 'Signaling by NOTCH4', 'Signaling by Nuclear Receptors', 'Signaling by Rho GTPases', 'Signaling by Rho GTPases, Miro GTPases and RHOBTB3', 'Signaling by TGF-beta Receptor Complex', 'Signaling by TGFB family members', 'Signaling by WNT', 'Smooth Muscle Contraction', 'Switching of origins to a post-replicative state', 'Synthesis of DNA', 'TCF dependent signaling in response to WNT', 'Telomere Maintenance', 'Transcriptional Regulation by VENTX', 'Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer', 'Transcriptional regulation by RUNX1', 'Transcriptional regulation by small RNAs', 'Transcriptional regulation of granulopoiesis', 'vRNA Synthesis'], ['Anchoring fibril formation', 'Apoptosis', 'Apoptotic cleavage of cellular proteins', 'Apoptotic execution phase', 'Assembly of collagen fibrils and other multimeric structures', 'Axon guidance', 'Binding and Uptake of Ligands by Scavenger Receptors', 'Breakdown of the nuclear lamina', 'Cell Cycle', 'Cell Cycle, Mitotic', 'Cell junction organization', 'Cell-Cell communication', 'Cellular responses to stimuli', 'Cellular responses to stress', 'Collagen biosynthesis and modifying enzymes', 'Collagen chain trimerization', 'Collagen degradation', 'Collagen formation', 'Crosslinking of collagen fibrils', 'Defective Intrinsic Pathway for Apoptosis', 'Degradation of the extracellular matrix', 'Depolymerisation of the Nuclear Lamina', \"Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models\", 'Developmental Biology', 'Disease', 'Diseases of programmed cell death', 'Diseases of signal transduction by growth factor receptors and second messengers', 'ECM proteoglycans', 'Extracellular matrix organization', 'Formation of the cornified envelope', 'IRE1alpha activates chaperones', 'Initiation of Nuclear Envelope (NE) Reformation', 'Integrin cell surface interactions', 'Keratinization', 'Laminin interactions', 'M Phase', 'Meiosis', 'Meiotic synapsis', 'Mitotic Anaphase', 'Mitotic Metaphase and Anaphase', 'Mitotic Prophase', 'NCAM signaling for neurite out-growth', 'NCAM1 interactions', 'Nervous system development', 'Neurodegenerative Diseases', 'Non-integrin membrane-ECM interactions', 'Nuclear Envelope (NE) Reassembly', 'Nuclear Envelope Breakdown', 'Oncogenic MAPK signaling', 'Programmed Cell Death', 'Reproduction', 'Scavenging by Class A Receptors', 'Signal Transduction', 'Signaling by BRAF and RAF1 fusions', 'Signaling by PDGF', 'Signaling by Receptor Tyrosine Kinases', 'Type I hemidesmosome assembly', 'Unfolded Protein Response (UPR)', 'Vesicle-mediated transport', 'XBP1(S) activates chaperone genes'], ['Adaptive Immune System', 'Cellular responses to stimuli', 'Cellular responses to stress', 'Costimulation by the CD28 family', 'ESR-mediated signaling', 'Estrogen-dependent gene expression', 'Gene expression (Transcription)', 'Generic Transcription Pathway', 'HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand', 'Immune System', 'Metabolism of proteins', 'Nuclear Receptor transcription pathway', 'Nuclear signaling by ERBB4', 'PD-1 signaling', 'Post-translational protein modification', 'RNA Polymerase II Transcription', 'STAT3 nuclear events downstream of ALK signaling', 'SUMO E3 ligases SUMOylate target proteins', 'SUMOylation', 'SUMOylation of intracellular receptors', 'Signal Transduction', 'Signaling by ALK', 'Signaling by ERBB4', 'Signaling by Nuclear Receptors', 'Signaling by Receptor Tyrosine Kinases'], ['Adaptive Immune System', 'Anchoring fibril formation', 'Apoptosis', 'Apoptotic cleavage of cellular proteins', 'Apoptotic execution phase', 'Assembly of collagen fibrils and other multimeric structures', 'Binding and Uptake of Ligands by Scavenger Receptors', 'Breakdown of the nuclear lamina', 'Cell Cycle', 'Cell Cycle, Mitotic', 'Cell surface interactions at the vascular wall', 'Cellular Senescence', 'Cellular responses to stimuli', 'Cellular responses to stress', 'Collagen biosynthesis and modifying enzymes', 'Collagen chain trimerization', 'Collagen degradation', 'Collagen formation', 'Crosslinking of collagen fibrils', 'Cytokine Signaling in Immune system', 'DNA Damage/Telomere Stress Induced Senescence', 'Defective Intrinsic Pathway for Apoptosis', 'Degradation of the extracellular matrix', 'Depolymerisation of the Nuclear Lamina', \"Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models\", 'Disease', 'Diseases of programmed cell death', 'ECM proteoglycans', 'Extracellular matrix organization', 'Formation of Senescence-Associated Heterochromatin Foci (SAHF)', 'GP1b-IX-V activation signalling', 'GPVI-mediated activation cascade', 'Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation', 'Gene expression (Transcription)', 'Generic Transcription Pathway', 'Hemostasis', 'Immune System', 'Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'Initiation of Nuclear Envelope (NE) Reformation', 'Integrin cell surface interactions', 'Interleukin-12 family signaling', 'Interleukin-12 signaling', 'M Phase', 'MET activates PTK2 signaling', 'MET promotes cell motility', 'Meiosis', 'Meiotic synapsis', 'Mitotic Anaphase', 'Mitotic Metaphase and Anaphase', 'Mitotic Prophase', 'Neurodegenerative Diseases', 'Non-integrin membrane-ECM interactions', 'Nuclear Envelope (NE) Reassembly', 'Nuclear Envelope Breakdown', 'Platelet Adhesion to exposed collagen', 'Platelet Aggregation (Plug Formation)', 'Platelet activation, signaling and aggregation', 'Programmed Cell Death', 'RHO GTPase cycle', 'RHOD GTPase cycle', 'RHOF GTPase cycle', 'RNA Polymerase II Transcription', 'RUNX2 regulates bone development', 'RUNX2 regulates osteoblast differentiation', 'Reproduction', 'Scavenging by Class A Receptors', 'Signal Transduction', 'Signaling by Interleukins', 'Signaling by MET', 'Signaling by Receptor Tyrosine Kinases', 'Signaling by Rho GTPases', 'Signaling by Rho GTPases, Miro GTPases and RHOBTB3', 'Syndecan interactions', 'Transcriptional regulation by RUNX2', 'Vesicle-mediated transport'], ['Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3', 'Adaptive Immune System', 'Cellular response to hypoxia', 'Cellular responses to stimuli', 'Cellular responses to stress', 'Circadian Clock', 'Cytokine Signaling in Immune system', 'Deubiquitination', 'Gene expression (Transcription)', 'Generic Transcription Pathway', 'HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand', 'Immune System', 'Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'Interleukin-4 and Interleukin-13 signaling', 'Metabolism of proteins', 'NOTCH1 Intracellular Domain Regulates Transcription', 'Neddylation', 'Nuclear Receptor transcription pathway', 'Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha', 'PTK6 Expression', 'PTK6 promotes HIF1A stabilization', 'Post-translational protein modification', 'RHO GTPase Effectors', 'RHO GTPases activate PKNs', 'RNA Polymerase II Transcription', 'RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs)', 'RUNX1 regulates transcription of genes involved in WNT signaling', 'RUNX2 regulates bone development', 'RUNX2 regulates osteoblast differentiation', 'Regulation of gene expression by Hypoxia-inducible Factor', 'STAT3 nuclear events downstream of ALK signaling', 'SUMO E3 ligases SUMOylate target proteins', 'SUMOylation', 'SUMOylation of intracellular receptors', 'Signal Transduction', 'Signaling by ALK', 'Signaling by Interleukins', 'Signaling by NOTCH', 'Signaling by NOTCH1', 'Signaling by Non-Receptor Tyrosine Kinases', 'Signaling by PTK6', 'Signaling by Receptor Tyrosine Kinases', 'Signaling by Rho GTPases', 'Signaling by Rho GTPases, Miro GTPases and RHOBTB3', 'Transcriptional regulation by RUNX1', 'Transcriptional regulation by RUNX2', 'Ub-specific processing proteases'], ['AKT phosphorylates targets in the cytosol', 'AKT phosphorylates targets in the nucleus', 'AKT-mediated inactivation of FOXO1A', 'Activation of BAD and translocation to mitochondria ', 'Activation of BH3-only proteins', 'Activation of NMDA receptors and postsynaptic events', 'Activation of the AP-1 family of transcription factors', 'Adaptive Immune System', 'Advanced glycosylation endproduct receptor signaling', 'Antiviral mechanism by IFN-stimulated genes', 'Apoptosis', 'Apoptotic factor-mediated response', 'Axon guidance', 'Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA', 'CD28 co-stimulation', 'CD28 dependent PI3K/Akt signaling', 'CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling', 'CTLA4 inhibitory signaling', 'Ca-dependent events', 'Cell Cycle', 'Cell Cycle, Mitotic', 'Cellular Senescence', 'Cellular response to heat stress', 'Cellular responses to stimuli', 'Cellular responses to stress', 'Constitutive Signaling by AKT1 E17K in Cancer', 'Costimulation by the CD28 family', 'Cyclin A:Cdk2-associated events at S phase entry', 'Cyclin E associated events during G1/S transition ', 'Cytochrome c-mediated apoptotic response', 'Cytokine Signaling in Immune system', 'Deactivation of the beta-catenin transactivating complex', 'Developmental Biology', 'Disease', 'Diseases of signal transduction by growth factor receptors and second messengers', 'Downregulation of ERBB2 signaling', 'Downregulation of ERBB2:ERBB3 signaling', 'ERK/MAPK targets', 'ERKs are inactivated', 'ESR-mediated signaling', 'Elastic fibre formation', 'Estrogen-dependent nuclear events downstream of ESR-membrane signaling', 'Estrogen-stimulated signaling through PRKCZ', 'Extra-nuclear estrogen signaling', 'Extracellular matrix organization', 'FCERI mediated MAPK activation', 'FCGR3A-mediated phagocytosis', 'FLT3 Signaling', 'FOXO-mediated transcription', 'Fc epsilon receptor (FCERI) signaling', 'Fcgamma receptor (FCGR) dependent phagocytosis', 'Formation of apoptosome', 'Frs2-mediated activation', 'G alpha (i) signalling events', 'G alpha (q) signalling events', 'G beta:gamma signalling through PI3Kgamma', 'G-protein beta:gamma signalling', 'G-protein mediated events', 'G1/S Transition', 'GPCR downstream signalling', 'Gastrin-CREB signalling pathway via PKC and MAPK', 'Gene expression (Transcription)', 'Generic Transcription Pathway', 'Golgi Cisternae Pericentriolar Stack Reorganization', 'Growth hormone receptor signaling', 'Hemostasis', 'ISG15 antiviral mechanism', 'Immune System', 'Infection with Mycobacterium tuberculosis', 'Infectious disease', 'Innate Immune System', 'Insulin receptor signalling cascade', 'Integrin signaling', 'Interferon Signaling', 'Interleukin-17 signaling', 'Interleukin-4 and Interleukin-13 signaling', 'Intracellular signaling by second messengers', 'Intrinsic Pathway for Apoptosis', 'KSRP (KHSRP) binds and destabilizes mRNA', 'L1CAM interactions', 'Leishmania infection', 'Leishmania phagocytosis', 'M Phase', 'MAP kinase activation', 'MAP2K and MAPK activation', 'MAPK family signaling cascades', 'MAPK targets/ Nuclear events mediated by MAP kinases', 'MAPK1 (ERK2) activation', 'MAPK1/MAPK3 signaling', 'MAPK3 (ERK1) activation', 'MTOR signalling', 'Membrane Trafficking', 'Metabolism', 'Metabolism of RNA', 'Metabolism of cofactors', 'Metabolism of nitric oxide: NOS3 activation and regulation', 'Metabolism of proteins', 'Metabolism of vitamins and cofactors', 'Mitotic G1 phase and G1/S transition', 'Mitotic Prophase', 'Molecules associated with elastic fibres', 'MyD88 cascade initiated on plasma membrane', 'MyD88 dependent cascade initiated on endosome', 'MyD88-independent TLR4 cascade ', 'MyD88:MAL(TIRAP) cascade initiated on plasma membrane', 'NCAM signaling for neurite out-growth', 'Negative feedback regulation of MAPK pathway', 'Negative regulation of FGFR1 signaling', 'Negative regulation of FGFR2 signaling', 'Negative regulation of FGFR3 signaling', 'Negative regulation of FGFR4 signaling', 'Negative regulation of MAPK pathway', 'Negative regulation of NOTCH4 signaling', 'Negative regulation of the PI3K/AKT network', 'Nervous system development', 'Neuronal System', 'Neurotransmitter receptors and postsynaptic signal transmission', 'Neutrophil degranulation', 'Nuclear Events (kinase and transcription factor activation)', 'Nuclear events stimulated by ALK signaling in cancer', 'Oncogene Induced Senescence', 'Oncogenic MAPK signaling', 'Opioid Signalling', 'Oxidative Stress Induced Senescence', 'PI3K/AKT Signaling in Cancer', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling', 'PIP3 activates AKT signaling', 'PLC beta mediated events', 'PTEN Regulation', 'PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1', 'Paradoxical activation of RAF signaling by kinase inactive BRAF', 'Parasite infection', 'Platelet Aggregation (Plug Formation)', 'Platelet activation, signaling and aggregation', 'Post NMDA receptor activation events', 'Post-translational protein modification', 'Post-translational protein phosphorylation', 'Programmed Cell Death', 'Prolonged ERK activation events', 'RAB GEFs exchange GTP for GDP on RABs', 'RAF-independent MAPK1/3 activation', 'RAF/MAP kinase cascade', 'RHO GTPase Effectors', 'RHO GTPases Activate NADPH Oxidases', 'RHO GTPases Activate WASPs and WAVEs', 'RNA Polymerase I Promoter Clearance', 'RNA Polymerase I Promoter Opening', 'RNA Polymerase I Transcription', 'RNA Polymerase II Transcription', 'RSK activation', 'RUNX2 regulates bone development', 'RUNX2 regulates genes involved in cell migration', 'RUNX2 regulates osteoblast differentiation', 'Rab regulation of trafficking', 'Recycling pathway of L1', 'Regulation of HSF1-mediated heat shock response', 'Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'Regulation of PTEN gene transcription', 'Regulation of PTEN stability and activity', 'Regulation of RUNX2 expression and activity', 'Regulation of TP53 Activity', 'Regulation of TP53 Activity through Acetylation', 'Regulation of TP53 Activity through Association with Co-factors', 'Regulation of TP53 Degradation', 'Regulation of TP53 Expression and Degradation', 'Regulation of actin dynamics for phagocytic cup formation', 'Regulation of beta-cell development', 'Regulation of gene expression in beta cells', 'Regulation of localization of FOXO transcription factors', 'Regulation of mRNA stability by proteins that bind AU-rich elements', 'Regulation of the apoptosome activity', 'Response of Mtb to phagocytosis', 'S Phase', 'SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription', 'Senescence-Associated Secretory Phenotype (SASP)', 'Signal Transduction', 'Signal attenuation', 'Signal transduction by L1', 'Signaling by ALK fusions and activated point mutants', 'Signaling by ALK in cancer', 'Signaling by Activin', 'Signaling by BMP', 'Signaling by BRAF and RAF1 fusions', 'Signaling by ERBB2', 'Signaling by FGFR', 'Signaling by FGFR1', 'Signaling by FGFR2', 'Signaling by FGFR3', 'Signaling by FGFR4', 'Signaling by GPCR', 'Signaling by Insulin receptor', 'Signaling by Interleukins', 'Signaling by MAP2K mutants', 'Signaling by MAPK mutants', 'Signaling by NODAL', 'Signaling by NOTCH', 'Signaling by NOTCH4', 'Signaling by NTRK1 (TRKA)', 'Signaling by NTRKs', 'Signaling by Non-Receptor Tyrosine Kinases', 'Signaling by Nuclear Receptors', 'Signaling by PTK6', 'Signaling by RAF1 mutants', 'Signaling by RAS mutants', 'Signaling by Receptor Tyrosine Kinases', 'Signaling by Rho GTPases', 'Signaling by Rho GTPases, Miro GTPases and RHOBTB3', 'Signaling by TGF-beta Receptor Complex', 'Signaling by TGFB family members', 'Signaling by VEGF', 'Signaling by WNT', 'Signaling by high-kinase activity BRAF mutants', 'Signaling by moderate kinase activity BRAF mutants', 'Signaling downstream of RAS mutants', 'Signalling to ERKs', 'Spry regulation of FGF signaling', 'Suppression of apoptosis', 'TCF dependent signaling in response to WNT', 'TP53 Regulates Metabolic Genes', 'TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation', 'TRIF(TICAM1)-mediated TLR4 signaling ', 'Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation', 'Thrombin signalling through proteinase activated receptors (PARs)', 'Toll Like Receptor 10 (TLR10) Cascade', 'Toll Like Receptor 2 (TLR2) Cascade', 'Toll Like Receptor 3 (TLR3) Cascade', 'Toll Like Receptor 4 (TLR4) Cascade', 'Toll Like Receptor 5 (TLR5) Cascade', 'Toll Like Receptor 7/8 (TLR7/8) Cascade', 'Toll Like Receptor 9 (TLR9) Cascade', 'Toll Like Receptor TLR1:TLR2 Cascade', 'Toll Like Receptor TLR6:TLR2 Cascade', 'Toll-like Receptor Cascades', 'Transcriptional Regulation by TP53', 'Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer', 'Transcriptional regulation by RUNX2', 'Translocation of SLC2A4 (GLUT4) to the plasma membrane', 'Transmission across Chemical Synapses', 'VEGFA-VEGFR2 Pathway', 'VEGFR2 mediated vascular permeability', 'Vesicle-mediated transport', 'eNOS activation', 'phospho-PLA2 pathway'], ['Activation of caspases through apoptosome-mediated cleavage', 'Adaptive Immune System', 'Amino acids regulate mTORC1', 'Apoptosis', 'Apoptosis induced DNA fragmentation', 'Apoptotic cleavage of cell adhesion  proteins', 'Apoptotic cleavage of cellular proteins', 'Apoptotic execution phase', 'Apoptotic factor-mediated response', 'Autophagy', 'Axon guidance', 'CD28 co-stimulation', 'CD28 dependent PI3K/Akt signaling', 'Caspase activation via Dependence Receptors in the absence of ligand', 'Caspase activation via extrinsic apoptotic signalling pathway', 'Caspase-mediated cleavage of cytoskeletal proteins', 'Cell death signalling via NRAGE, NRIF and NADE', 'Cellular response to heat stress', 'Cellular response to starvation', 'Cellular responses to stimuli', 'Cellular responses to stress', 'Constitutive Signaling by AKT1 E17K in Cancer', 'Costimulation by the CD28 family', 'Cytochrome c-mediated apoptotic response', 'Cytokine Signaling in Immune system', 'Death Receptor Signalling', 'Degradation of the extracellular matrix', 'Developmental Biology', 'Disease', 'Diseases of signal transduction by growth factor receptors and second messengers', 'ECM proteoglycans', 'Energy dependent regulation of mTOR by LKB1-AMPK', 'Extracellular matrix organization', 'Gene expression (Transcription)', 'Generic Transcription Pathway', 'HSF1-dependent transactivation', 'Immune System', 'Infectious disease', 'Interferon Signaling', 'Interferon gamma signaling', 'Intracellular signaling by second messengers', 'Intrinsic Pathway for Apoptosis', 'L1CAM interactions', 'MAPK family signaling cascades', 'MAPK1/MAPK3 signaling', 'MTOR signalling', 'Macroautophagy', 'NADE modulates death signalling', 'NCAM signaling for neurite out-growth', 'NCAM1 interactions', 'Nervous system development', 'Other interleukin signaling', 'PI3K/AKT Signaling in Cancer', 'PIP3 activates AKT signaling', 'PTEN Regulation', 'Potential therapeutics for SARS', 'Programmed Cell Death', 'Pyroptosis', 'RAF/MAP kinase cascade', 'RNA Polymerase II Transcription', 'Regulated Necrosis', 'Regulation of PTEN gene transcription', 'Regulation of TP53 Activity', 'Regulation of TP53 Degradation', 'Regulation of TP53 Expression and Degradation', 'SARS-CoV Infections', 'SMAC (DIABLO) binds to IAPs ', 'SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes ', 'SMAC, XIAP-regulated apoptotic response', 'Signal Transduction', 'Signal transduction by L1', 'Signaling by Hippo', 'Signaling by Interleukins', 'Signaling by Receptor Tyrosine Kinases', 'Signaling by VEGF', 'Stimulation of the cell death response by PAK-2p34', 'TP53 Regulates Metabolic Genes', 'Transcriptional Regulation by TP53', 'VEGFA-VEGFR2 Pathway', 'VEGFR2 mediated vascular permeability', 'mTORC1-mediated signalling', 'p75 NTR receptor-mediated signalling']]\n"
     ]
    }
   ],
   "source": [
    "print(pathways)"
   ],
   "metadata": {
    "collapsed": false,
    "pycharm": {
     "name": "#%%\n"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {
    "pycharm": {
     "name": "#%%\n"
    }
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[{'interaction': [{'interactionID': '13173', 'drug': '4984', 'target': '1508', 'interactionType': 'ANTIBODY BINDING', 'source': '1331', 'expEvidence': '16425', 'id': '13173'}, {'interactionID': '13404', 'drug': '5223', 'target': '1508', 'interactionType': 'ANTIBODY BINDING', 'source': '1331', 'expEvidence': '16698', 'id': '13404'}, {'interactionID': '13122', 'drug': '4951', 'target': '1508', 'interactionType': 'ANTIBODY BINDING', 'source': '1331', 'expEvidence': '16385', 'id': '13122'}, {'interactionID': '13172', 'drug': '4983', 'target': '1508', 'interactionType': 'ANTIBODY BINDING', 'source': '1331', 'expEvidence': '16424', 'id': '13172'}, {'interactionID': '13163', 'drug': '4975', 'target': '1508', 'interactionType': 'ANTIBODY BINDING', 'source': '1331', 'expEvidence': '16415', 'id': '13163'}], 'drug': [{'drugID': '4975', 'drugName': 'Rituximab', 'id': '4975'}, {'drugID': '4984', 'drugName': 'Ibritumomab tiuxetan', 'id': '4984'}, {'drugID': '4951', 'drugName': 'Ofatumumab', 'id': '4951'}, {'drugID': '4983', 'drugName': 'Obinutuzumab', 'id': '4983'}, {'drugID': '5223', 'drugName': 'Ocrelizumab', 'id': '5223'}], 'target': {'id': '1508', 'targetID': '1508', 'targetName': 'MS4A1', 'targetSpecies': 'Homo sapiens', 'targetType': 'Surface antigen', 'uniprotID': 'P11836'}, 'expEvidence': [{'expID': '16415', 'assayRelation': '', 'assayDescription': 'Mechanism of Action', 'expSourceSet': '5', 'id': '16415'}, {'expID': '16385', 'assayRelation': '', 'assayDescription': 'Mechanism of Action', 'expSourceSet': '5', 'id': '16385'}, {'expID': '16424', 'assayRelation': '', 'assayDescription': 'Mechanism of Action', 'expSourceSet': '5', 'id': '16424'}, {'expID': '16425', 'assayType': 'Kd', 'assayValueMedian': '14.0', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'Mechanism of Action', 'expSourceSet': '5', 'id': '16425'}, {'expID': '16698', 'assayType': 'Kd', 'assayValueMedian': '0.794', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': '', 'expSourceSet': '48', 'id': '16698'}], 'source': [{'sourceID': '5', 'sourceDatabase': '5', 'id': '5'}, {'sourceID': '48', 'sourceDatabase': '48', 'id': '48'}, {'sourceID': '1331', 'sourceDatabase': '0', 'id': '1331'}], 'database': [{'databaseID': '48', 'databaseName': 'IUPHAR', 'downloadURL': 'http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=198', 'id': '48'}, {'databaseID': '5', 'databaseName': 'DRUG LABEL', 'downloadURL': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022276s003lbl.pdf', 'id': '5'}, {'databaseID': '0', 'databaseName': 'DrugCentral', 'id': '0'}]}, {'interaction': [{'interactionID': '13072', 'drug': '4923', 'target': '1498', 'interactionType': 'ANTIBODY BINDING', 'source': '1331', 'expEvidence': '16324', 'id': '13072'}, {'interactionID': '5059', 'drug': '1585', 'target': '958', 'interactionType': '', 'source': '1331', 'expEvidence': '6520', 'id': '5059'}, {'interactionID': '13073', 'drug': '4924', 'target': '1498', 'interactionType': 'ANTIBODY BINDING', 'source': '1331', 'expEvidence': '16325', 'id': '13073'}, {'interactionID': '10693', 'drug': '3611', 'target': '958', 'interactionType': '', 'source': '1331', 'expEvidence': '13662', 'id': '10693'}, {'interactionID': '10685', 'drug': '3604', 'target': '958', 'interactionType': '', 'source': '1331', 'expEvidence': '13652', 'id': '10685'}], 'drug': [{'drugID': '4923', 'drugName': 'Nivolumab', 'id': '4923'}, {'drugID': '3611', 'drugName': 'Tiratricol', 'id': '3611'}, {'drugID': '3604', 'drugName': 'Thyropropic acid', 'id': '3604'}, {'drugID': '4924', 'drugName': 'Pembrolizumab', 'id': '4924'}, {'drugID': '1585', 'drugName': 'Liothyronine', 'id': '1585'}], 'target': [{'id': '1498', 'targetID': '1498', 'targetName': 'PDCD1', 'targetSpecies': 'Homo sapiens', 'targetType': 'Membrane receptor', 'uniprotID': 'Q15116'}, {'id': '958', 'targetID': '958', 'targetName': 'PCNA', 'targetSpecies': 'Homo sapiens', 'targetType': 'Unclassified', 'uniprotID': 'P12004'}], 'expEvidence': [{'expID': '13652', 'assayType': 'IC50', 'assayValueMedian': '1.70E+04', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'Inhibition of human recombinant PCNA interaction with PIP box protein N-5-carboxyfluorescein-SAVLQKKITDYFHPKK after 30 mins by fluorescence polarization assay', 'expSourceSet': '1062', 'id': '13652'}, {'expID': '6520', 'assayType': 'IC50', 'assayValueMedian': '3.63E+03', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'Inhibition of human recombinant PCNA interaction with PIP box protein N-5-carboxyfluorescein-SAVLQKKITDYFHPKK after 30 mins by fluorescence polarization assay', 'expSourceSet': '507', 'id': '6520'}, {'expID': '16325', 'assayType': 'Kd', 'assayValueMedian': '0.100', 'assayUnits': 'nM', 'assayRelation': '~', 'assayDescription': 'Mechanism of Action', 'expSourceSet': '48', 'id': '16325'}, {'expID': '13662', 'assayType': 'IC50', 'assayValueMedian': '2.51E+04', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'Inhibition of human recombinant PCNA interaction with PIP box protein N-5-carboxyfluorescein-SAVLQKKITDYFHPKK after 30 mins by fluorescence polarization assay', 'expSourceSet': '1065', 'id': '13662'}, {'expID': '16324', 'assayRelation': '', 'assayDescription': 'Mechanism of Action', 'expSourceSet': '8', 'id': '16324'}], 'literature': {'literatureID': '8', 'PubMedID': '17276408', 'id': '8', 'litID': '8', 'pubMedID': '17276408'}, 'source': [{'sourceID': '8', 'sourceLiterature': '8', 'sourceDatabase': '0', 'id': '8'}, {'sourceID': '507', 'sourceDatabase': '507', 'id': '507'}, {'sourceID': '48', 'sourceDatabase': '48', 'id': '48'}, {'sourceID': '1331', 'sourceDatabase': '0', 'id': '1331'}, {'sourceID': '1062', 'sourceDatabase': '1062', 'id': '1062'}, {'sourceID': '1065', 'sourceDatabase': '1065', 'id': '1065'}], 'database': [{'databaseID': '48', 'databaseName': 'IUPHAR', 'downloadURL': 'http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=198', 'id': '48'}, {'databaseID': '507', 'databaseName': 'CHEMBL', 'downloadURL': 'https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1544', 'id': '507'}, {'databaseID': '1065', 'databaseName': 'CHEMBL', 'downloadURL': 'https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL41632', 'id': '1065'}, {'databaseID': '0', 'databaseName': 'DrugCentral', 'id': '0'}, {'databaseID': '1062', 'databaseName': 'CHEMBL', 'downloadURL': 'https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL291053', 'id': '1062'}]}, None, {'interaction': [{'interactionID': '6555', 'drug': '1962', 'target': '286', 'interactionType': '', 'source': '1331', 'expEvidence': '8404', 'id': '6555'}, {'interactionID': '1686', 'drug': '700', 'target': '286', 'interactionType': 'MODULATOR', 'source': '1331', 'expEvidence': '2328', 'id': '1686'}, {'interactionID': '6219', 'drug': '1882', 'target': '286', 'interactionType': '', 'source': '1331', 'expEvidence': '7964', 'id': '6219'}, {'interactionID': '12403', 'drug': '4497', 'target': '286', 'interactionType': 'AGONIST', 'source': '1331', 'expEvidence': '15511', 'id': '12403'}, {'interactionID': '7784', 'drug': '2351', 'target': '286', 'interactionType': 'ANTAGONIST', 'source': '1331', 'expEvidence': '9971', 'id': '7784'}, {'interactionID': '2546', 'drug': '870', 'target': '286', 'interactionType': 'AGONIST', 'source': '1331', 'expEvidence': '3413', 'id': '2546'}, {'interactionID': '6783', 'drug': '2033', 'target': '286', 'interactionType': '', 'source': '1331', 'expEvidence': '8736', 'id': '6783'}, {'interactionID': '10082', 'drug': '3032', 'target': '286', 'interactionType': '', 'source': '1331', 'expEvidence': '12923', 'id': '10082'}, {'interactionID': '3577', 'drug': '1110', 'target': '286', 'interactionType': '', 'source': '1331', 'expEvidence': '4688', 'id': '3577'}, {'interactionID': '3554', 'drug': '1095', 'target': '286', 'interactionType': '', 'source': '1331', 'expEvidence': '4667', 'id': '3554'}, {'interactionID': '3548', 'drug': '1094', 'target': '286', 'interactionType': '', 'source': '1331', 'expEvidence': '4657', 'id': '3548'}, {'interactionID': '3499', 'drug': '1082', 'target': '286', 'interactionType': 'AGONIST', 'source': '1331', 'expEvidence': '4587', 'id': '3499'}, {'interactionID': '8872', 'drug': '2561', 'target': '286', 'interactionType': 'MODULATOR', 'source': '1331', 'expEvidence': '11358', 'id': '8872'}, {'interactionID': '5349', 'drug': '1659', 'target': '286', 'interactionType': '', 'source': '1331', 'expEvidence': '6891', 'id': '5349'}, {'interactionID': '3435', 'drug': '1057', 'target': '286', 'interactionType': 'AGONIST', 'source': '1331', 'expEvidence': '4507', 'id': '3435'}, {'interactionID': '3459', 'drug': '1064', 'target': '286', 'interactionType': 'AGONIST', 'source': '1331', 'expEvidence': '4542', 'id': '3459'}, {'interactionID': '495', 'drug': '214', 'target': '286', 'interactionType': '', 'source': '1331', 'expEvidence': '646', 'id': '495'}, {'interactionID': '7456', 'drug': '2279', 'target': '286', 'interactionType': '', 'source': '1331', 'expEvidence': '9569', 'id': '7456'}, {'interactionID': '12737', 'drug': '4857', 'target': '286', 'interactionType': 'AGONIST', 'source': '1331', 'expEvidence': '15954', 'id': '12737'}, {'interactionID': '12027', 'drug': '4334', 'target': '286', 'interactionType': 'MODULATOR', 'source': '1331', 'expEvidence': '15124', 'id': '12027'}, {'interactionID': '9171', 'drug': '2655', 'target': '286', 'interactionType': '', 'source': '1331', 'expEvidence': '11756', 'id': '9171'}, {'interactionID': '3458', 'drug': '1059', 'target': '286', 'interactionType': 'AGONIST', 'source': '1331', 'expEvidence': '4540', 'id': '3458'}, {'interactionID': '4001', 'drug': '1255', 'target': '286', 'interactionType': 'ANTAGONIST', 'source': '1331', 'expEvidence': '5230', 'id': '4001'}, {'interactionID': '4404', 'drug': '1364', 'target': '286', 'interactionType': '', 'source': '1331', 'expEvidence': '5666', 'id': '4404'}, {'interactionID': '10153', 'drug': '3188', 'target': '286', 'interactionType': 'AGONIST', 'source': '1331', 'expEvidence': '13034', 'id': '10153'}, {'interactionID': '11955', 'drug': '4308', 'target': '286', 'interactionType': 'AGONIST', 'source': '1331', 'expEvidence': '15039', 'id': '11955'}, {'interactionID': '3455', 'drug': '1058', 'target': '286', 'interactionType': '', 'source': '1331', 'expEvidence': '4535', 'id': '3455'}, {'interactionID': '5297', 'drug': '1637', 'target': '286', 'interactionType': '', 'source': '1331', 'expEvidence': '6818', 'id': '5297'}, {'interactionID': '9292', 'drug': '2709', 'target': '286', 'interactionType': 'MODULATOR', 'source': '1331', 'expEvidence': '11918', 'id': '9292'}, {'interactionID': '7722', 'drug': '2342', 'target': '286', 'interactionType': 'AGONIST', 'source': '1331', 'expEvidence': '9906', 'id': '7722'}, {'interactionID': '4206', 'drug': '1328', 'target': '286', 'interactionType': '', 'source': '1331', 'expEvidence': '5492', 'id': '4206'}, {'interactionID': '8328', 'drug': '2477', 'target': '286', 'interactionType': '', 'source': '1331', 'expEvidence': '10694', 'id': '8328'}, {'interactionID': '5012', 'drug': '1572', 'target': '286', 'interactionType': '', 'source': '1331', 'expEvidence': '6461', 'id': '5012'}, {'interactionID': '2587', 'drug': '875', 'target': '286', 'interactionType': 'AGONIST', 'source': '1331', 'expEvidence': '3459', 'id': '2587'}, {'interactionID': '12641', 'drug': '4773', 'target': '286', 'interactionType': '', 'source': '1331', 'expEvidence': '15825', 'id': '12641'}, {'interactionID': '12735', 'drug': '4855', 'target': '286', 'interactionType': 'AGONIST', 'source': '1331', 'expEvidence': '15952', 'id': '12735'}, {'interactionID': '5981', 'drug': '1805', 'target': '286', 'interactionType': '', 'source': '1331', 'expEvidence': '7616', 'id': '5981'}, {'interactionID': '10189', 'drug': '3248', 'target': '286', 'interactionType': 'AGONIST', 'source': '1331', 'expEvidence': '13091', 'id': '10189'}, {'interactionID': '4413', 'drug': '1368', 'target': '286', 'interactionType': '', 'source': '1331', 'expEvidence': '5683', 'id': '4413'}, {'interactionID': '10148', 'drug': '3187', 'target': '286', 'interactionType': 'AGONIST', 'source': '1331', 'expEvidence': '13026', 'id': '10148'}, {'interactionID': '10287', 'drug': '3366', 'target': '286', 'interactionType': '', 'source': '1331', 'expEvidence': '13204', 'id': '10287'}, {'interactionID': '3465', 'drug': '1067', 'target': '286', 'interactionType': '', 'source': '1331', 'expEvidence': '4548', 'id': '3465'}, {'interactionID': '1375', 'drug': '610', 'target': '286', 'interactionType': '', 'source': '1331', 'expEvidence': '1905', 'id': '1375'}, {'interactionID': '12633', 'drug': '4749', 'target': '286', 'interactionType': 'MODULATOR', 'source': '1331', 'expEvidence': '15817', 'id': '12633'}, {'interactionID': '10654', 'drug': '3553', 'target': '286', 'interactionType': '', 'source': '1331', 'expEvidence': '13616', 'id': '10654'}, {'interactionID': '2080', 'drug': '779', 'target': '286', 'interactionType': '', 'source': '1331', 'expEvidence': '2859', 'id': '2080'}, {'interactionID': '10365', 'drug': '3482', 'target': '286', 'interactionType': 'AGONIST', 'source': '1331', 'expEvidence': '13286', 'id': '10365'}, {'interactionID': '5501', 'drug': '1714', 'target': '286', 'interactionType': 'AGONIST', 'source': '1331', 'expEvidence': '7067', 'id': '5501'}], 'drug': [{'drugID': '4497', 'drugName': 'Estradiol acetate', 'id': '4497'}, {'drugID': '2709', 'drugName': 'Toremifene', 'id': '2709'}, {'drugID': '1255', 'drugName': 'Fulvestrant', 'id': '1255'}, {'drugID': '1067', 'drugName': 'Estriol succinate', 'id': '1067'}, {'drugID': '3553', 'drugName': 'Stallimycin', 'id': '3553'}, {'drugID': '1882', 'drugName': 'Nandrolone phenpropionate', 'id': '1882'}, {'drugID': '1059', 'drugName': 'Estradiol cypionate', 'id': '1059'}, {'drugID': '4773', 'drugName': 'Ethyl hydroxybenzoate', 'id': '4773'}, {'drugID': '3248', 'drugName': 'Fosfestrol', 'id': '3248'}, {'drugID': '1064', 'drugName': 'Estradiol valerate', 'id': '1064'}, {'drugID': '1714', 'drugName': 'Mestranol', 'id': '1714'}, {'drugID': '1058', 'drugName': 'Estradiol benzoate', 'id': '1058'}, {'drugID': '3482', 'drugName': 'Polyestradiol phosphate', 'id': '3482'}, {'drugID': '1094', 'drugName': 'Ethylestrenol', 'id': '1094'}, {'drugID': '3188', 'drugName': 'Estrone', 'id': '3188'}, {'drugID': '4308', 'drugName': 'Lasofoxifene', 'id': '4308'}, {'drugID': '3366', 'drugName': 'Moxestrol', 'id': '3366'}, {'drugID': '3032', 'drugName': 'Bithionol', 'id': '3032'}, {'drugID': '1082', 'drugName': 'Ethinylestradiol', 'id': '1082'}, {'drugID': '779', 'drugName': 'Danazol', 'id': '779'}, {'drugID': '1962', 'drugName': 'Norethisterone', 'id': '1962'}, {'drugID': '1328', 'drugName': 'Gossypol', 'id': '1328'}, {'drugID': '875', 'drugName': 'Diethylstilbestrol', 'id': '875'}, {'drugID': '2033', 'drugName': 'Oxymetholone', 'id': '2033'}, {'drugID': '2279', 'drugName': 'Progesterone', 'id': '2279'}, {'drugID': '1368', 'drugName': 'Hexestrol', 'id': '1368'}, {'drugID': '4857', 'drugName': 'Estrone sulphate', 'id': '4857'}, {'drugID': '2477', 'drugName': 'Stanozolol', 'id': '2477'}, {'drugID': '1110', 'drugName': 'Etonogestrel', 'id': '1110'}, {'drugID': '1572', 'drugName': 'Levonorgestrel', 'id': '1572'}, {'drugID': '610', 'drugName': 'Chlorotrianisene', 'id': '610'}, {'drugID': '870', 'drugName': 'Dienestrol', 'id': '870'}, {'drugID': '2655', 'drugName': 'Tibolone', 'id': '2655'}, {'drugID': '3187', 'drugName': 'Estriol', 'id': '3187'}, {'drugID': '1095', 'drugName': 'Etynodiol', 'id': '1095'}, {'drugID': '1057', 'drugName': 'Estradiol', 'id': '1057'}, {'drugID': '4334', 'drugName': 'Bazedoxifene', 'id': '4334'}, {'drugID': '2561', 'drugName': 'Tamoxifen', 'id': '2561'}, {'drugID': '1637', 'drugName': 'Masoprocol', 'id': '1637'}, {'drugID': '4749', 'drugName': 'Ospemifene', 'id': '4749'}, {'drugID': '700', 'drugName': 'Clomifene', 'id': '700'}, {'drugID': '1659', 'drugName': 'Medroxyprogesterone', 'id': '1659'}, {'drugID': '1364', 'drugName': 'Hexachlorophene', 'id': '1364'}, {'drugID': '214', 'drugName': 'Androstenediol', 'id': '214'}, {'drugID': '2342', 'drugName': 'Quinestrol', 'id': '2342'}, {'drugID': '2351', 'drugName': 'Raloxifene', 'id': '2351'}, {'drugID': '1805', 'drugName': 'Mifepristone', 'id': '1805'}, {'drugID': '4855', 'drugName': 'Conjugated estrogens', 'id': '4855'}], 'target': {'id': '286', 'targetID': '286', 'targetName': 'ESR1', 'targetSpecies': 'Homo sapiens', 'targetType': 'Nuclear hormone receptor', 'uniprotID': 'P03372'}, 'expEvidence': [{'expID': '13616', 'assayType': 'IC50', 'assayValueMedian': '20.0', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'Tested for 50% inhibition of generation of Human estrogen receptor polymerase chain reaction(PCR) products', 'expSourceSet': '1055', 'id': '13616'}, {'expID': '13204', 'assayType': 'IC50', 'assayValueMedian': '2.51', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'Binding affinity for estrogen receptor of rabbit uterine skeletal muscle tissue', 'expSourceSet': '1025', 'id': '13204'}, {'expID': '646', 'assayType': 'IC50', 'assayValueMedian': '182', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'Binding affinity at human recombinant ERalpha', 'expSourceSet': '87', 'id': '646'}, {'expID': '9971', 'assayType': 'IC50', 'assayValueMedian': '0.398', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': '', 'expSourceSet': '217', 'id': '9971'}, {'expID': '4688', 'assayRelation': '', 'assayDescription': '', 'expSourceSet': '4', 'id': '4688'}, {'expID': '4667', 'assayRelation': '', 'assayDescription': '', 'expSourceSet': '4', 'id': '4667'}, {'expID': '7067', 'assayType': 'Ki', 'assayValueMedian': '5.22', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'DRUGMATRIX: Estrogen ERalpha radioligand binding (ligand: [3H] Estradiol)', 'expSourceSet': '76', 'id': '7067'}, {'expID': '6891', 'assayType': 'IC50', 'assayValueMedian': '933', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'Inhibition of binding to human estrogen receptor', 'expSourceSet': '540', 'id': '6891'}, {'expID': '5230', 'assayType': 'Ki', 'assayValueMedian': '0.240', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': '', 'expSourceSet': '1', 'id': '5230'}, {'expID': '13091', 'assayRelation': '', 'assayDescription': 'Mechanism of Action; CHEMBL2093866; PROTEIN FAMILY', 'expSourceSet': '12', 'id': '13091'}, {'expID': '4548', 'assayType': 'Ki', 'assayValueMedian': '0.479', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'DRUGMATRIX: Estrogen ERalpha radioligand binding (ligand: [3H] Estradiol)', 'expSourceSet': '355', 'id': '4548'}, {'expID': '5683', 'assayType': 'Ki', 'assayValueMedian': '0.0501', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'Antagonist', 'expSourceSet': '450', 'id': '5683'}, {'expID': '15952', 'assayRelation': '', 'assayDescription': 'Mechanism of Action', 'expSourceSet': '5', 'id': '15952'}, {'expID': '4542', 'assayRelation': '', 'assayDescription': 'Mechanism of Action; CHEMBL206; SINGLE PROTEIN', 'expSourceSet': '12', 'id': '4542'}, {'expID': '13286', 'assayRelation': '', 'assayDescription': 'Mechanism of Action; CHEMBL206; SINGLE PROTEIN', 'expSourceSet': '12', 'id': '13286'}, {'expID': '8736', 'assayRelation': '', 'assayDescription': '', 'expSourceSet': '4', 'id': '8736'}, {'expID': '11756', 'assayType': 'Ki', 'assayValueMedian': '124', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'DRUGMATRIX: Estrogen ERalpha radioligand binding (ligand: [3H] Estradiol)', 'expSourceSet': '2', 'id': '11756'}, {'expID': '3413', 'assayRelation': '', 'assayDescription': '', 'expSourceSet': '9', 'id': '3413'}, {'expID': '5666', 'assayType': 'IC50', 'assayValueMedian': '2.14E+03', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'PUBCHEM_BIOASSAY: Estrogen Receptor-alpha Coactivator Binding Inhibitors Dose Response Confirmation. (Class of assay: confirmatory) [Related pubchem assays: 629 (Primary screen preceding this dose response confirmation assay.)]', 'expSourceSet': '447', 'id': '5666'}, {'expID': '15511', 'assayRelation': '', 'assayDescription': 'Mechanism of Action; CHEMBL206; SINGLE PROTEIN', 'expSourceSet': '12', 'id': '15511'}, {'expID': '15124', 'assayType': 'IC50', 'assayValueMedian': '0.603', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'Inhibition of binding to recombinant human ERalpha by scintillation proximity assay', 'expSourceSet': '12', 'id': '15124'}, {'expID': '10694', 'assayType': 'Ki', 'assayValueMedian': '32.0', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'DRUGMATRIX: Estrogen ERalpha radioligand binding (ligand: [3H] Estradiol)', 'expSourceSet': '2', 'id': '10694'}, {'expID': '15825', 'assayType': 'EC50', 'assayValueMedian': '3.80E+04', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'Agonist activity at human estrogen receptor-alpha by yeast two-hybrid assay in presence of SRC1', 'expSourceSet': '1247', 'id': '15825'}, {'expID': '2328', 'assayType': 'Ki', 'assayValueMedian': '1.30', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'DRUGMATRIX: Estrogen ERalpha radioligand binding (ligand: [3H] Estradiol)', 'expSourceSet': '76', 'id': '2328'}, {'expID': '4507', 'assayType': 'EC50', 'assayValueMedian': '0.0501', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': '', 'expSourceSet': '1', 'id': '4507'}, {'expID': '15817', 'assayType': 'IC50', 'assayValueMedian': '827', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': '', 'expSourceSet': '1', 'id': '15817'}, {'expID': '11358', 'assayType': 'Ki', 'assayValueMedian': '30.9', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'Displacement of [2,4,6,7-3H]estradiol from human ERalpha expressed in HeLa cells after 18 hrs by liquid scintillation counting', 'expSourceSet': '12', 'id': '11358'}, {'expID': '9906', 'assayRelation': '', 'assayDescription': '', 'expSourceSet': '9', 'id': '9906'}, {'expID': '4587', 'assayType': 'Kd', 'assayValueMedian': '0.148', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': '', 'expSourceSet': '1', 'id': '4587'}, {'expID': '5492', 'assayType': 'IC50', 'assayValueMedian': '2.57E+03', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'PUBCHEM_BIOASSAY: Estrogen Receptor-alpha Coactivator Binding Inhibitors Dose Response Confirmation. (Class of assay: confirmatory) [Related pubchem assays: 629 (Primary screen preceding this dose response confirmation assay.)]', 'expSourceSet': '434', 'id': '5492'}, {'expID': '4540', 'assayRelation': '', 'assayDescription': 'Mechanism of Action; CHEMBL206; SINGLE PROTEIN', 'expSourceSet': '12', 'id': '4540'}, {'expID': '12923', 'assayType': 'IC50', 'assayValueMedian': '3.98E+03', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'PUBCHEM_BIOASSAY: Estrogen Receptor-alpha Coactivator Binding Inhibitors Dose Response Confirmation. (Class of assay: confirmatory) [Related pubchem assays: 629 (Primary screen preceding this dose response confirmation assay.)]', 'expSourceSet': '981', 'id': '12923'}, {'expID': '6818', 'assayType': 'IC50', 'assayValueMedian': '2.24E+04', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'PUBCHEM_BIOASSAY: Estrogen Receptor-alpha Coactivator Binding Inhibitors Dose Response Confirmation. (Class of assay: confirmatory) [Related pubchem assays: 629 (Primary screen preceding this dose response confirmation assay.)]', 'expSourceSet': '531', 'id': '6818'}, {'expID': '13034', 'assayType': 'EC50', 'assayValueMedian': '0.708', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'Activation of estrogen response element in HeLa cells stably transfected with human Estrogen receptor alpha.', 'expSourceSet': '12', 'id': '13034'}, {'expID': '4657', 'assayType': 'Ki', 'assayValueMedian': '320', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'DRUGMATRIX: Estrogen ERalpha radioligand binding (ligand: [3H] Estradiol)', 'expSourceSet': '2', 'id': '4657'}, {'expID': '4535', 'assayType': 'Ki', 'assayValueMedian': '18.0', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'DRUGMATRIX: Estrogen ERalpha radioligand binding (ligand: [3H] Estradiol)', 'expSourceSet': '2', 'id': '4535'}, {'expID': '11918', 'assayRelation': '', 'assayDescription': '', 'expSourceSet': '1', 'id': '11918'}, {'expID': '8404', 'assayType': 'Ki', 'assayValueMedian': '231', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'DRUGMATRIX: Estrogen ERalpha radioligand binding (ligand: [3H] Estradiol)', 'expSourceSet': '2', 'id': '8404'}, {'expID': '13026', 'assayType': 'Ki', 'assayValueMedian': '2.00', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'Mechanism of Action', 'expSourceSet': '7', 'id': '13026'}, {'expID': '2859', 'assayType': 'Ki', 'assayValueMedian': '5.08E+03', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'DRUGMATRIX: Estrogen ERalpha radioligand binding (ligand: [3H] Estradiol)', 'expSourceSet': '2', 'id': '2859'}, {'expID': '3459', 'assayType': 'Ki', 'assayValueMedian': '0.219', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'Displacement of [3H]Estradiol from human recombinant estrogen receptor alpha expressed in Sf9 cells after 2 hrs', 'expSourceSet': '12', 'id': '3459'}, {'expID': '7964', 'assayType': 'EC50', 'assayValueMedian': '200', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': '', 'expSourceSet': '4', 'id': '7964'}, {'expID': '9569', 'assayRelation': '', 'assayDescription': '', 'expSourceSet': '4', 'id': '9569'}, {'expID': '6461', 'assayRelation': '', 'assayDescription': '', 'expSourceSet': '4', 'id': '6461'}, {'expID': '15954', 'assayRelation': '', 'assayDescription': 'Mechanism of Action', 'expSourceSet': '5', 'id': '15954'}, {'expID': '7616', 'assayType': 'IC50', 'assayValueMedian': '5.01E+03', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'Antagonist activity at estrogen receptor by Gal4-DNA binding domain-hormone receptor LBD one-hybrid assay', 'expSourceSet': '589', 'id': '7616'}, {'expID': '15039', 'assayType': 'IC50', 'assayValueMedian': '1.29', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'Binding affinity for human estrogen receptor alpha', 'expSourceSet': '204', 'id': '15039'}, {'expID': '1905', 'assayRelation': '', 'assayDescription': '', 'expSourceSet': '4', 'id': '1905'}], 'source': [{'sourceID': '76', 'sourceDatabase': '76', 'id': '76'}, {'sourceID': '355', 'sourceDatabase': '355', 'id': '355'}, {'sourceID': '531', 'sourceDatabase': '531', 'id': '531'}, {'sourceID': '1025', 'sourceDatabase': '1025', 'id': '1025'}, {'sourceID': '540', 'sourceDatabase': '540', 'id': '540'}, {'sourceID': '5', 'sourceDatabase': '5', 'id': '5'}, {'sourceID': '1055', 'sourceDatabase': '1055', 'id': '1055'}, {'sourceID': '217', 'sourceDatabase': '217', 'id': '217'}, {'sourceID': '1247', 'sourceDatabase': '1247', 'id': '1247'}, {'sourceID': '87', 'sourceDatabase': '87', 'id': '87'}, {'sourceID': '450', 'sourceDatabase': '450', 'id': '450'}, {'sourceID': '434', 'sourceDatabase': '434', 'id': '434'}, {'sourceID': '204', 'sourceDatabase': '204', 'id': '204'}, {'sourceID': '589', 'sourceDatabase': '589', 'id': '589'}, {'sourceID': '9', 'sourceDatabase': '9', 'id': '9'}, {'sourceID': '2', 'sourceDatabase': '2', 'id': '2'}, {'sourceID': '981', 'sourceDatabase': '981', 'id': '981'}, {'sourceID': '1331', 'sourceDatabase': '0', 'id': '1331'}, {'sourceID': '447', 'sourceDatabase': '447', 'id': '447'}, {'sourceID': '7', 'sourceDatabase': '7', 'id': '7'}, {'sourceID': '4', 'sourceDatabase': '4', 'id': '4'}, {'sourceID': '1', 'sourceDatabase': '1', 'id': '1'}, {'sourceID': '12', 'sourceDatabase': '12', 'id': '12'}], 'database': [{'databaseID': '531', 'databaseName': 'CHEMBL', 'downloadURL': 'https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL52', 'id': '531'}, {'databaseID': '9', 'databaseName': 'DRUGBANK', 'downloadURL': 'https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1367478', 'id': '9'}, {'databaseID': '1', 'databaseName': 'WOMBAT-PK', 'downloadURL': 'https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200749', 'id': '1'}, {'databaseID': '981', 'databaseName': 'CHEMBL', 'downloadURL': 'https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL290106', 'id': '981'}, {'databaseID': '2', 'databaseName': 'DRUG MATRIX', 'id': '2'}, {'databaseID': '4', 'databaseName': 'WOMBAT-PK', 'id': '4'}, {'databaseID': '540', 'databaseName': 'CHEMBL', 'downloadURL': 'https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL717', 'id': '540'}, {'databaseID': '1247', 'databaseName': 'CHEMBL', 'downloadURL': 'https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL15841', 'id': '1247'}, {'databaseID': '589', 'databaseName': 'CHEMBL', 'downloadURL': 'https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1276308', 'id': '589'}, {'databaseID': '1055', 'databaseName': 'CHEMBL', 'downloadURL': 'https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL11252', 'id': '1055'}, {'databaseID': '0', 'databaseName': 'DrugCentral', 'id': '0'}, {'databaseID': '76', 'databaseName': 'DRUG MATRIX', 'downloadURL': 'https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1113', 'id': '76'}, {'databaseID': '450', 'databaseName': 'IUPHAR', 'downloadURL': 'http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2823', 'id': '450'}, {'databaseID': '12', 'databaseName': 'CHEMBL', 'downloadURL': 'https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1489', 'id': '12'}, {'databaseID': '217', 'databaseName': 'WOMBAT-PK', 'downloadURL': 'http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2398', 'id': '217'}, {'databaseID': '355', 'databaseName': 'CHEMBL', 'downloadURL': 'https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL193482', 'id': '355'}, {'databaseID': '447', 'databaseName': 'CHEMBL', 'downloadURL': 'https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL496', 'id': '447'}, {'databaseID': '87', 'databaseName': 'CHEMBL', 'downloadURL': 'https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL440283', 'id': '87'}, {'databaseID': '434', 'databaseName': 'CHEMBL', 'downloadURL': 'https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL51483', 'id': '434'}, {'databaseID': '5', 'databaseName': 'DRUG LABEL', 'downloadURL': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022276s003lbl.pdf', 'id': '5'}, {'databaseID': '204', 'databaseName': 'CHEMBL', 'downloadURL': 'https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL557555', 'id': '204'}, {'databaseID': '1025', 'databaseName': 'CHEMBL', 'downloadURL': 'https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1628161', 'id': '1025'}, {'databaseID': '7', 'databaseName': 'IUPHAR', 'downloadURL': 'http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2334', 'id': '7'}]}, None, None, {'interaction': [{'interactionID': '10787', 'drug': '3707', 'target': '1389', 'interactionType': '', 'source': '1331', 'expEvidence': '13787', 'id': '10787'}, {'interactionID': '13402', 'drug': '5222', 'target': '1389', 'interactionType': 'INHIBITOR', 'source': '1331', 'expEvidence': '16696', 'id': '13402'}, {'interactionID': '13054', 'drug': '4907', 'target': '1389', 'interactionType': 'INHIBITOR', 'source': '1331', 'expEvidence': '16300', 'id': '13054'}, {'interactionID': '13378', 'drug': '5203', 'target': '1389', 'interactionType': 'INHIBITOR', 'source': '1331', 'expEvidence': '16671', 'id': '13378'}], 'drug': [{'drugID': '5222', 'drugName': 'Niraparib', 'id': '5222'}, {'drugID': '3707', 'drugName': 'Chlorthenoxazine', 'id': '3707'}, {'drugID': '5203', 'drugName': 'Rucaparib', 'id': '5203'}, {'drugID': '4907', 'drugName': 'Olaparib', 'id': '4907'}], 'target': {'id': '1389', 'targetID': '1389', 'targetName': 'PARP1', 'targetSpecies': 'Homo sapiens', 'targetType': 'Enzyme', 'uniprotID': 'P09874'}, 'expEvidence': [{'expID': '13787', 'assayType': 'IC50', 'assayValueMedian': '8.51E+03', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'The compound was tested for poly(ADP-ribose)-polymerase (PARP) inhibition', 'expSourceSet': '1083', 'id': '13787'}, {'expID': '16300', 'assayType': 'IC50', 'assayValueMedian': '5.00', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': '', 'expSourceSet': '8', 'id': '16300'}, {'expID': '16671', 'assayType': 'IC50', 'assayValueMedian': '3.16', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': '', 'expSourceSet': '169', 'id': '16671'}, {'expID': '16696', 'assayType': 'IC50', 'assayValueMedian': '3.98', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': '', 'expSourceSet': '48', 'id': '16696'}], 'literature': [{'literatureID': '8', 'PubMedID': '17276408', 'id': '8', 'litID': '8', 'pubMedID': '17276408'}, {'literatureID': '169', 'PubMedID': '15740719', 'id': '169', 'litID': '169', 'pubMedID': '15740719'}], 'source': [{'sourceID': '1083', 'sourceDatabase': '1083', 'id': '1083'}, {'sourceID': '8', 'sourceLiterature': '8', 'sourceDatabase': '0', 'id': '8'}, {'sourceID': '169', 'sourceLiterature': '169', 'sourceDatabase': '0', 'id': '169'}, {'sourceID': '48', 'sourceDatabase': '48', 'id': '48'}, {'sourceID': '1331', 'sourceDatabase': '0', 'id': '1331'}], 'database': [{'databaseID': '48', 'databaseName': 'IUPHAR', 'downloadURL': 'http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=198', 'id': '48'}, {'databaseID': '1083', 'databaseName': 'CHEMBL', 'downloadURL': 'https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL124815', 'id': '1083'}, {'databaseID': '0', 'databaseName': 'DrugCentral', 'id': '0'}]}, None, {'interaction': [{'interactionID': '13344', 'drug': '5151', 'target': '1539', 'interactionType': 'ANTIBODY BINDING', 'source': '1331', 'expEvidence': '16635', 'id': '13344'}, {'interactionID': '6552', 'drug': '1962', 'target': '514', 'interactionType': 'AGONIST', 'source': '1331', 'expEvidence': '8401', 'id': '6552'}, {'interactionID': '5008', 'drug': '1572', 'target': '514', 'interactionType': 'AGONIST', 'source': '1331', 'expEvidence': '6455', 'id': '5008'}, {'interactionID': '9362', 'drug': '2725', 'target': '514', 'interactionType': '', 'source': '1331', 'expEvidence': '12012', 'id': '9362'}, {'interactionID': '8878', 'drug': '2561', 'target': '514', 'interactionType': '', 'source': '1331', 'expEvidence': '11366', 'id': '8878'}, {'interactionID': '7495', 'drug': '2285', 'target': '514', 'interactionType': '', 'source': '1331', 'expEvidence': '9619', 'id': '7495'}, {'interactionID': '5340', 'drug': '1659', 'target': '514', 'interactionType': 'AGONIST', 'source': '1331', 'expEvidence': '6881', 'id': '5340'}, {'interactionID': '2386', 'drug': '824', 'target': '514', 'interactionType': '', 'source': '1331', 'expEvidence': '3170', 'id': '2386'}, {'interactionID': '7724', 'drug': '2345', 'target': '514', 'interactionType': 'AGONIST', 'source': '1331', 'expEvidence': '9908', 'id': '7724'}, {'interactionID': '5368', 'drug': '1667', 'target': '514', 'interactionType': 'AGONIST', 'source': '1331', 'expEvidence': '6913', 'id': '5368'}, {'interactionID': '6570', 'drug': '1968', 'target': '514', 'interactionType': 'AGONIST', 'source': '1331', 'expEvidence': '8430', 'id': '6570'}, {'interactionID': '2064', 'drug': '779', 'target': '514', 'interactionType': 'AGONIST', 'source': '1331', 'expEvidence': '2843', 'id': '2064'}, {'interactionID': '3059', 'drug': '968', 'target': '514', 'interactionType': 'AGONIST', 'source': '1331', 'expEvidence': '4038', 'id': '3059'}, {'interactionID': '2547', 'drug': '871', 'target': '514', 'interactionType': 'AGONIST', 'source': '1331', 'expEvidence': '3414', 'id': '2547'}, {'interactionID': '8321', 'drug': '2475', 'target': '514', 'interactionType': '', 'source': '1331', 'expEvidence': '10686', 'id': '8321'}, {'interactionID': '6562', 'drug': '1965', 'target': '514', 'interactionType': 'AGONIST', 'source': '1331', 'expEvidence': '8417', 'id': '6562'}, {'interactionID': '2392', 'drug': '828', 'target': '514', 'interactionType': '', 'source': '1331', 'expEvidence': '3180', 'id': '2392'}, {'interactionID': '3576', 'drug': '1110', 'target': '514', 'interactionType': 'AGONIST', 'source': '1331', 'expEvidence': '4687', 'id': '3576'}, {'interactionID': '11589', 'drug': '4189', 'target': '514', 'interactionType': 'AGONIST', 'source': '1331', 'expEvidence': '14627', 'id': '11589'}, {'interactionID': '6558', 'drug': '1963', 'target': '514', 'interactionType': 'AGONIST', 'source': '1331', 'expEvidence': '8410', 'id': '6558'}, {'interactionID': '9174', 'drug': '2655', 'target': '514', 'interactionType': '', 'source': '1331', 'expEvidence': '11761', 'id': '9174'}, {'interactionID': '2367', 'drug': '818', 'target': '514', 'interactionType': 'AGONIST', 'source': '1331', 'expEvidence': '3148', 'id': '2367'}, {'interactionID': '4141', 'drug': '1291', 'target': '514', 'interactionType': '', 'source': '1331', 'expEvidence': '5408', 'id': '4141'}, {'interactionID': '5969', 'drug': '1805', 'target': '514', 'interactionType': 'ANTAGONIST', 'source': '1331', 'expEvidence': '7601', 'id': '5969'}, {'interactionID': '6106', 'drug': '1832', 'target': '514', 'interactionType': '', 'source': '1331', 'expEvidence': '7786', 'id': '6106'}, {'interactionID': '13401', 'drug': '5221', 'target': '1539', 'interactionType': 'ANTIBODY BINDING', 'source': '1331', 'expEvidence': '16695', 'id': '13401'}, {'interactionID': '3091', 'drug': '975', 'target': '514', 'interactionType': 'AGONIST', 'source': '1331', 'expEvidence': '4065', 'id': '3091'}, {'interactionID': '3969', 'drug': '1225', 'target': '514', 'interactionType': 'AGONIST', 'source': '1331', 'expEvidence': '5181', 'id': '3969'}, {'interactionID': '7446', 'drug': '2279', 'target': '514', 'interactionType': 'AGONIST', 'source': '1331', 'expEvidence': '9549', 'id': '7446'}, {'interactionID': '3552', 'drug': '1095', 'target': '514', 'interactionType': 'AGONIST', 'source': '1331', 'expEvidence': '4663', 'id': '3552'}, {'interactionID': '2396', 'drug': '829', 'target': '514', 'interactionType': '', 'source': '1331', 'expEvidence': '3188', 'id': '2396'}, {'interactionID': '11264', 'drug': '4166', 'target': '514', 'interactionType': 'MODULATOR', 'source': '1331', 'expEvidence': '14286', 'id': '11264'}, {'interactionID': '2038', 'drug': '766', 'target': '514', 'interactionType': '', 'source': '1331', 'expEvidence': '2814', 'id': '2038'}, {'interactionID': '4007', 'drug': '1255', 'target': '514', 'interactionType': '', 'source': '1331', 'expEvidence': '5237', 'id': '4007'}, {'interactionID': '6539', 'drug': '1959', 'target': '514', 'interactionType': 'AGONIST', 'source': '1331', 'expEvidence': '8375', 'id': '6539'}], 'drug': [{'drugID': '1963', 'drugName': 'Norethindrone acetate', 'id': '1963'}, {'drugID': '5151', 'drugName': 'Atezolizumab', 'id': '5151'}, {'drugID': '1255', 'drugName': 'Fulvestrant', 'id': '1255'}, {'drugID': '824', 'drugName': 'Dexamethasone', 'id': '824'}, {'drugID': '2725', 'drugName': 'Triamcinolone', 'id': '2725'}, {'drugID': '1291', 'drugName': 'Gestodene', 'id': '1291'}, {'drugID': '1968', 'drugName': 'Norgestimate', 'id': '1968'}, {'drugID': '975', 'drugName': 'Dydrogesterone', 'id': '975'}, {'drugID': '779', 'drugName': 'Danazol', 'id': '779'}, {'drugID': '1962', 'drugName': 'Norethisterone', 'id': '1962'}, {'drugID': '968', 'drugName': 'Drospirenone', 'id': '968'}, {'drugID': '4166', 'drugName': 'Ulipristal', 'id': '4166'}, {'drugID': '4189', 'drugName': 'Hydroxyprogesterone caproate', 'id': '4189'}, {'drugID': '2279', 'drugName': 'Progesterone', 'id': '2279'}, {'drugID': '5221', 'drugName': 'Avelumab', 'id': '5221'}, {'drugID': '1572', 'drugName': 'Levonorgestrel', 'id': '1572'}, {'drugID': '1965', 'drugName': 'Norethynodrel', 'id': '1965'}, {'drugID': '1110', 'drugName': 'Etonogestrel', 'id': '1110'}, {'drugID': '2285', 'drugName': 'Promegestone', 'id': '2285'}, {'drugID': '2655', 'drugName': 'Tibolone', 'id': '2655'}, {'drugID': '1095', 'drugName': 'Etynodiol', 'id': '1095'}, {'drugID': '871', 'drugName': 'Dienogest', 'id': '871'}, {'drugID': '1225', 'drugName': 'Fluticasone propionate', 'id': '1225'}, {'drugID': '2561', 'drugName': 'Tamoxifen', 'id': '2561'}, {'drugID': '1659', 'drugName': 'Medroxyprogesterone', 'id': '1659'}, {'drugID': '1959', 'drugName': 'Norelgestromin', 'id': '1959'}, {'drugID': '2345', 'drugName': 'Quingestanol acetate', 'id': '2345'}, {'drugID': '1667', 'drugName': 'Megestrol acetate', 'id': '1667'}, {'drugID': '766', 'drugName': 'Cyproterone acetate', 'id': '766'}, {'drugID': '818', 'drugName': 'Desogestrel', 'id': '818'}, {'drugID': '1805', 'drugName': 'Mifepristone', 'id': '1805'}, {'drugID': '2475', 'drugName': 'Spironolactone', 'id': '2475'}, {'drugID': '828', 'drugName': 'Dexamethasone palmitate', 'id': '828'}, {'drugID': '829', 'drugName': 'Dexamethasone valerate', 'id': '829'}, {'drugID': '1832', 'drugName': 'Mometasone furoate', 'id': '1832'}], 'target': [{'id': '514', 'targetID': '514', 'targetName': 'PGR', 'targetSpecies': 'Homo sapiens', 'targetType': 'Nuclear hormone receptor', 'uniprotID': 'P06401'}, {'id': '1539', 'targetID': '1539', 'targetName': 'CD274', 'targetSpecies': 'Homo sapiens', 'targetType': 'CD molecules', 'uniprotID': 'Q9NZQ7'}], 'expEvidence': [{'expID': '9619', 'assayType': 'Kd', 'assayValueMedian': '0.398', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'Binding affinity to progesterone receptor', 'expSourceSet': '748', 'id': '9619'}, {'expID': '4687', 'assayRelation': '', 'assayDescription': '', 'expSourceSet': '1', 'id': '4687'}, {'expID': '8430', 'assayRelation': '', 'assayDescription': '', 'expSourceSet': '1', 'id': '8430'}, {'expID': '14627', 'assayType': 'IC50', 'assayValueMedian': '21.7', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'human recombinant PR-B isoform in Sf9 cells', 'expSourceSet': '169', 'id': '14627'}, {'expID': '5408', 'assayRelation': '', 'assayDescription': '', 'expSourceSet': '4', 'id': '5408'}, {'expID': '7601', 'assayType': 'Ki', 'assayValueMedian': '1.82', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': '', 'expSourceSet': '1', 'id': '7601'}, {'expID': '3170', 'assayType': 'Ki', 'assayValueMedian': '562', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'Displacement of [3H]-methyltrienolone from human progesterone receptor expressed in HEK293 cells', 'expSourceSet': '266', 'id': '3170'}, {'expID': '6913', 'assayRelation': '', 'assayDescription': '', 'expSourceSet': '9', 'id': '6913'}, {'expID': '3414', 'assayRelation': '', 'assayDescription': 'Mechanism of Action', 'expSourceSet': '5', 'id': '3414'}, {'expID': '8410', 'assayType': 'ED50', 'assayValueMedian': '0.00550', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': '', 'expSourceSet': '1', 'id': '8410'}, {'expID': '4065', 'assayType': 'Ki', 'assayValueMedian': '126', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': '', 'expSourceSet': '14', 'id': '4065'}, {'expID': '4663', 'assayRelation': '', 'assayDescription': '', 'expSourceSet': '1', 'id': '4663'}, {'expID': '16695', 'assayType': 'IC50', 'assayValueMedian': '0.0794', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': '', 'expSourceSet': '48', 'id': '16695'}, {'expID': '3188', 'assayType': 'Ki', 'assayValueMedian': '562', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': '', 'expSourceSet': '266', 'id': '3188'}, {'expID': '7786', 'assayType': 'EC50', 'assayValueMedian': '0.126', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': '', 'expSourceSet': '4', 'id': '7786'}, {'expID': '11761', 'assayRelation': '', 'assayDescription': '', 'expSourceSet': '4', 'id': '11761'}, {'expID': '11366', 'assayType': 'IC50', 'assayValueMedian': '129', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': '', 'expSourceSet': '851', 'id': '11366'}, {'expID': '10686', 'assayType': 'EC50', 'assayValueMedian': '936', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': '', 'expSourceSet': '4', 'id': '10686'}, {'expID': '9549', 'assayType': 'ED50', 'assayValueMedian': '0.133', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': '', 'expSourceSet': '1', 'id': '9549'}, {'expID': '3180', 'assayType': 'Ki', 'assayValueMedian': '562', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': '', 'expSourceSet': '266', 'id': '3180'}, {'expID': '16635', 'assayType': 'Kd', 'assayValueMedian': '1.00', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': '', 'expSourceSet': '48', 'id': '16635'}, {'expID': '4038', 'assayType': 'EC50', 'assayValueMedian': '0.0316', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': '', 'expSourceSet': '1', 'id': '4038'}, {'expID': '5181', 'assayType': 'EC50', 'assayValueMedian': '0.170', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': '', 'expSourceSet': '4', 'id': '5181'}, {'expID': '8375', 'assayRelation': '', 'assayDescription': '', 'expSourceSet': '1', 'id': '8375'}, {'expID': '5237', 'assayType': 'IC50', 'assayValueMedian': '0.209', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': '', 'expSourceSet': '410', 'id': '5237'}, {'expID': '2843', 'assayRelation': '', 'assayDescription': '', 'expSourceSet': '1', 'id': '2843'}, {'expID': '14286', 'assayType': 'IC50', 'assayValueMedian': '0.200', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'Mechanism of Action; CHEMBL208; SINGLE PROTEIN', 'expSourceSet': '7', 'id': '14286'}, {'expID': '6455', 'assayType': 'ED50', 'assayValueMedian': '0.000160', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': '', 'expSourceSet': '1', 'id': '6455'}, {'expID': '3148', 'assayRelation': '', 'assayDescription': '', 'expSourceSet': '1', 'id': '3148'}, {'expID': '2814', 'assayType': 'IC50', 'assayValueMedian': '0.210', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': '', 'expSourceSet': '4', 'id': '2814'}, {'expID': '6881', 'assayType': 'EC50', 'assayValueMedian': '0.257', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': '', 'expSourceSet': '1', 'id': '6881'}, {'expID': '12012', 'assayRelation': '', 'assayDescription': '', 'expSourceSet': '4', 'id': '12012'}, {'expID': '8417', 'assayRelation': '', 'assayDescription': 'Mechanism of Action; CHEMBL208; SINGLE PROTEIN', 'expSourceSet': '12', 'id': '8417'}, {'expID': '8401', 'assayType': 'ED50', 'assayValueMedian': '0.00550', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': '', 'expSourceSet': '1', 'id': '8401'}, {'expID': '9908', 'assayRelation': '', 'assayDescription': 'Mechanism of Action', 'expSourceSet': '20', 'id': '9908'}], 'literature': {'literatureID': '169', 'PubMedID': '15740719', 'id': '169', 'litID': '169', 'pubMedID': '15740719'}, 'source': [{'sourceID': '5', 'sourceDatabase': '5', 'id': '5'}, {'sourceID': '410', 'sourceDatabase': '410', 'id': '410'}, {'sourceID': '169', 'sourceLiterature': '169', 'sourceDatabase': '0', 'id': '169'}, {'sourceID': '748', 'sourceDatabase': '748', 'id': '748'}, {'sourceID': '20', 'sourceDatabase': '20', 'id': '20'}, {'sourceID': '851', 'sourceDatabase': '851', 'id': '851'}, {'sourceID': '266', 'sourceDatabase': '266', 'id': '266'}, {'sourceID': '9', 'sourceDatabase': '9', 'id': '9'}, {'sourceID': '48', 'sourceDatabase': '48', 'id': '48'}, {'sourceID': '1331', 'sourceDatabase': '0', 'id': '1331'}, {'sourceID': '7', 'sourceDatabase': '7', 'id': '7'}, {'sourceID': '1', 'sourceDatabase': '1', 'id': '1'}, {'sourceID': '4', 'sourceDatabase': '4', 'id': '4'}, {'sourceID': '14', 'sourceDatabase': '14', 'id': '14'}, {'sourceID': '12', 'sourceDatabase': '12', 'id': '12'}], 'database': [{'databaseID': '9', 'databaseName': 'DRUGBANK', 'downloadURL': 'https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1367478', 'id': '9'}, {'databaseID': '410', 'databaseName': 'CHEMBL', 'downloadURL': 'https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1358', 'id': '410'}, {'databaseID': '48', 'databaseName': 'IUPHAR', 'downloadURL': 'http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=198', 'id': '48'}, {'databaseID': '1', 'databaseName': 'WOMBAT-PK', 'downloadURL': 'https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200749', 'id': '1'}, {'databaseID': '4', 'databaseName': 'WOMBAT-PK', 'id': '4'}, {'databaseID': '266', 'databaseName': 'CHEMBL', 'downloadURL': 'https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL384467', 'id': '266'}, {'databaseID': '14', 'databaseName': 'IUPHAR', 'downloadURL': 'http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1188', 'id': '14'}, {'databaseID': '0', 'databaseName': 'DrugCentral', 'id': '0'}, {'databaseID': '20', 'databaseName': 'KEGG DRUG', 'downloadURL': 'http://www.kegg.jp/entry/D01582', 'id': '20'}, {'databaseID': '12', 'databaseName': 'CHEMBL', 'downloadURL': 'https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1489', 'id': '12'}, {'databaseID': '851', 'databaseName': 'CHEMBL', 'downloadURL': 'https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL83', 'id': '851'}, {'databaseID': '5', 'databaseName': 'DRUG LABEL', 'downloadURL': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022276s003lbl.pdf', 'id': '5'}, {'databaseID': '748', 'databaseName': 'CHEMBL', 'downloadURL': 'https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL196003', 'id': '748'}, {'databaseID': '7', 'databaseName': 'IUPHAR', 'downloadURL': 'http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2334', 'id': '7'}]}, None, {'interaction': [{'interactionID': '3729', 'drug': '1183', 'target': '285', 'interactionType': '', 'source': '1331', 'expEvidence': '4874', 'id': '3729'}, {'interactionID': '3967', 'drug': '1223', 'target': '285', 'interactionType': 'ANTAGONIST', 'source': '1331', 'expEvidence': '5178', 'id': '3967'}, {'interactionID': '2387', 'drug': '824', 'target': '285', 'interactionType': '', 'source': '1331', 'expEvidence': '3171', 'id': '2387'}, {'interactionID': '2251', 'drug': '792', 'target': '650', 'interactionType': '', 'source': '1331', 'expEvidence': '3049', 'id': '2251'}, {'interactionID': '7452', 'drug': '2279', 'target': '285', 'interactionType': '', 'source': '1331', 'expEvidence': '9557', 'id': '7452'}, {'interactionID': '5978', 'drug': '1805', 'target': '285', 'interactionType': '', 'source': '1331', 'expEvidence': '7613', 'id': '5978'}, {'interactionID': '6732', 'drug': '2011', 'target': '285', 'interactionType': 'AGONIST', 'source': '1331', 'expEvidence': '8663', 'id': '6732'}, {'interactionID': '875', 'drug': '367', 'target': '285', 'interactionType': 'ANTAGONIST', 'source': '1331', 'expEvidence': '1148', 'id': '875'}, {'interactionID': '7313', 'drug': '2245', 'target': '285', 'interactionType': '', 'source': '1331', 'expEvidence': '9433', 'id': '7313'}, {'interactionID': '9230', 'drug': '2698', 'target': '285', 'interactionType': '', 'source': '1331', 'expEvidence': '11828', 'id': '9230'}, {'interactionID': '3061', 'drug': '968', 'target': '285', 'interactionType': '', 'source': '1331', 'expEvidence': '4040', 'id': '3061'}, {'interactionID': '5291', 'drug': '1637', 'target': '285', 'interactionType': '', 'source': '1331', 'expEvidence': '6809', 'id': '5291'}, {'interactionID': '6218', 'drug': '1882', 'target': '285', 'interactionType': 'AGONIST', 'source': '1331', 'expEvidence': '7963', 'id': '6218'}, {'interactionID': '12381', 'drug': '4454', 'target': '285', 'interactionType': 'AGONIST', 'source': '1331', 'expEvidence': '15482', 'id': '12381'}, {'interactionID': '498', 'drug': '214', 'target': '285', 'interactionType': '', 'source': '1331', 'expEvidence': '650', 'id': '498'}, {'interactionID': '10286', 'drug': '3356', 'target': '285', 'interactionType': 'AGONIST', 'source': '1331', 'expEvidence': '13201', 'id': '10286'}, {'interactionID': '3848', 'drug': '1210', 'target': '285', 'interactionType': 'AGONIST', 'source': '1331', 'expEvidence': '5043', 'id': '3848'}, {'interactionID': '10837', 'drug': '3927', 'target': '285', 'interactionType': '', 'source': '1331', 'expEvidence': '13861', 'id': '10837'}, {'interactionID': '3753', 'drug': '1193', 'target': '285', 'interactionType': '', 'source': '1331', 'expEvidence': '4910', 'id': '3753'}, {'interactionID': '5330', 'drug': '1650', 'target': '285', 'interactionType': '', 'source': '1331', 'expEvidence': '6872', 'id': '5330'}, {'interactionID': '8331', 'drug': '2477', 'target': '285', 'interactionType': 'AGONIST', 'source': '1331', 'expEvidence': '10699', 'id': '8331'}, {'interactionID': '2039', 'drug': '766', 'target': '285', 'interactionType': 'ANTAGONIST', 'source': '1331', 'expEvidence': '2815', 'id': '2039'}, {'interactionID': '2397', 'drug': '829', 'target': '285', 'interactionType': '', 'source': '1331', 'expEvidence': '3190', 'id': '2397'}, {'interactionID': '10282', 'drug': '3341', 'target': '285', 'interactionType': 'AGONIST', 'source': '1331', 'expEvidence': '13194', 'id': '10282'}, {'interactionID': '3551', 'drug': '1094', 'target': '285', 'interactionType': 'AGONIST', 'source': '1331', 'expEvidence': '4662', 'id': '3551'}, {'interactionID': '12472', 'drug': '4628', 'target': '285', 'interactionType': 'ANTAGONIST', 'source': '1331', 'expEvidence': '15607', 'id': '12472'}, {'interactionID': '10695', 'drug': '3611', 'target': '285', 'interactionType': '', 'source': '1331', 'expEvidence': '13664', 'id': '10695'}, {'interactionID': '8323', 'drug': '2475', 'target': '285', 'interactionType': '', 'source': '1331', 'expEvidence': '10688', 'id': '8323'}, {'interactionID': '2393', 'drug': '828', 'target': '285', 'interactionType': '', 'source': '1331', 'expEvidence': '3182', 'id': '2393'}, {'interactionID': '9175', 'drug': '2655', 'target': '285', 'interactionType': '', 'source': '1331', 'expEvidence': '11762', 'id': '9175'}, {'interactionID': '3513', 'drug': '1082', 'target': '285', 'interactionType': '', 'source': '1331', 'expEvidence': '4605', 'id': '3513'}, {'interactionID': '6557', 'drug': '1962', 'target': '285', 'interactionType': '', 'source': '1331', 'expEvidence': '8409', 'id': '6557'}, {'interactionID': '4667', 'drug': '1440', 'target': '285', 'interactionType': '', 'source': '1331', 'expEvidence': '6029', 'id': '4667'}, {'interactionID': '9288', 'drug': '2707', 'target': '650', 'interactionType': '', 'source': '1331', 'expEvidence': '11911', 'id': '9288'}, {'interactionID': '6561', 'drug': '1963', 'target': '285', 'interactionType': '', 'source': '1331', 'expEvidence': '8415', 'id': '6561'}, {'interactionID': '5343', 'drug': '1659', 'target': '285', 'interactionType': '', 'source': '1331', 'expEvidence': '6885', 'id': '5343'}, {'interactionID': '6782', 'drug': '2033', 'target': '285', 'interactionType': 'AGONIST', 'source': '1331', 'expEvidence': '8734', 'id': '6782'}, {'interactionID': '494', 'drug': '213', 'target': '285', 'interactionType': '', 'source': '1331', 'expEvidence': '645', 'id': '494'}, {'interactionID': '2085', 'drug': '779', 'target': '285', 'interactionType': 'AGONIST', 'source': '1331', 'expEvidence': '2866', 'id': '2085'}, {'interactionID': '11193', 'drug': '4146', 'target': '285', 'interactionType': 'AGONIST', 'source': '1331', 'expEvidence': '14255', 'id': '11193'}, {'interactionID': '3444', 'drug': '1057', 'target': '285', 'interactionType': '', 'source': '1331', 'expEvidence': '4524', 'id': '3444'}, {'interactionID': '8999', 'drug': '2608', 'target': '285', 'interactionType': 'AGONIST', 'source': '1331', 'expEvidence': '11550', 'id': '8999'}, {'interactionID': '6457', 'drug': '1933', 'target': '285', 'interactionType': 'ANTAGONIST', 'source': '1331', 'expEvidence': '8284', 'id': '6457'}, {'interactionID': '3606', 'drug': '1122', 'target': '285', 'interactionType': '', 'source': '1331', 'expEvidence': '4725', 'id': '3606'}, {'interactionID': '6217', 'drug': '1881', 'target': '285', 'interactionType': 'AGONIST', 'source': '1331', 'expEvidence': '7962', 'id': '6217'}, {'interactionID': '12451', 'drug': '4609', 'target': '285', 'interactionType': 'AGONIST', 'source': '1331', 'expEvidence': '15576', 'id': '12451'}, {'interactionID': '8992', 'drug': '2607', 'target': '285', 'interactionType': 'AGONIST', 'source': '1331', 'expEvidence': '11538', 'id': '8992'}, {'interactionID': '6215', 'drug': '1879', 'target': '285', 'interactionType': 'AGONIST', 'source': '1331', 'expEvidence': '7960', 'id': '6215'}, {'interactionID': '3039', 'drug': '965', 'target': '285', 'interactionType': 'AGONIST', 'source': '1331', 'expEvidence': '4015', 'id': '3039'}], 'drug': [{'drugID': '1963', 'drugName': 'Norethindrone acetate', 'id': '1963'}, {'drugID': '1933', 'drugName': 'Nilutamide', 'id': '1933'}, {'drugID': '4628', 'drugName': 'Enzalutamide', 'id': '4628'}, {'drugID': '1882', 'drugName': 'Nandrolone phenpropionate', 'id': '1882'}, {'drugID': '824', 'drugName': 'Dexamethasone', 'id': '824'}, {'drugID': '4609', 'drugName': 'Testosterone enantate', 'id': '4609'}, {'drugID': '3611', 'drugName': 'Tiratricol', 'id': '3611'}, {'drugID': '779', 'drugName': 'Danazol', 'id': '779'}, {'drugID': '1879', 'drugName': 'Nandrolone', 'id': '1879'}, {'drugID': '1962', 'drugName': 'Norethisterone', 'id': '1962'}, {'drugID': '968', 'drugName': 'Drospirenone', 'id': '968'}, {'drugID': '1183', 'drugName': 'Floxacillin', 'id': '1183'}, {'drugID': '965', 'drugName': 'Drostanolone propionate', 'id': '965'}, {'drugID': '2607', 'drugName': 'Testosterone', 'id': '2607'}, {'drugID': '2033', 'drugName': 'Oxymetholone', 'id': '2033'}, {'drugID': '213', 'drugName': 'Androisoxazole', 'id': '213'}, {'drugID': '2279', 'drugName': 'Progesterone', 'id': '2279'}, {'drugID': '2477', 'drugName': 'Stanozolol', 'id': '2477'}, {'drugID': '2698', 'drugName': 'Tolfenamic acid', 'id': '2698'}, {'drugID': '1057', 'drugName': 'Estradiol', 'id': '1057'}, {'drugID': '1193', 'drugName': 'Flufenamic acid', 'id': '1193'}, {'drugID': '1881', 'drugName': 'Nandrolone decanoate', 'id': '1881'}, {'drugID': '4146', 'drugName': 'Testosterone propionate', 'id': '4146'}, {'drugID': '1440', 'drugName': 'Indomethacin', 'id': '1440'}, {'drugID': '2707', 'drugName': 'Topotecan', 'id': '2707'}, {'drugID': '3356', 'drugName': 'Methyltestosterone', 'id': '3356'}, {'drugID': '1805', 'drugName': 'Mifepristone', 'id': '1805'}, {'drugID': '828', 'drugName': 'Dexamethasone palmitate', 'id': '828'}, {'drugID': '367', 'drugName': 'Bicalutamide', 'id': '367'}, {'drugID': '3341', 'drugName': 'Mestanolone', 'id': '3341'}, {'drugID': '3927', 'drugName': 'Androstanolone', 'id': '3927'}, {'drugID': '1094', 'drugName': 'Ethylestrenol', 'id': '1094'}, {'drugID': '1122', 'drugName': 'Exemestane', 'id': '1122'}, {'drugID': '1082', 'drugName': 'Ethinylestradiol', 'id': '1082'}, {'drugID': '2608', 'drugName': 'Testosterone undecanoate', 'id': '2608'}, {'drugID': '792', 'drugName': 'Deferoxamine', 'id': '792'}, {'drugID': '2655', 'drugName': 'Tibolone', 'id': '2655'}, {'drugID': '2245', 'drugName': 'Prednisolone', 'id': '2245'}, {'drugID': '4454', 'drugName': 'Testosterone cypionate', 'id': '4454'}, {'drugID': '1223', 'drugName': 'Flutamide', 'id': '1223'}, {'drugID': '1210', 'drugName': 'Fluoxymesterone', 'id': '1210'}, {'drugID': '1637', 'drugName': 'Masoprocol', 'id': '1637'}, {'drugID': '2011', 'drugName': 'Oxandrolone', 'id': '2011'}, {'drugID': '1659', 'drugName': 'Medroxyprogesterone', 'id': '1659'}, {'drugID': '214', 'drugName': 'Androstenediol', 'id': '214'}, {'drugID': '766', 'drugName': 'Cyproterone acetate', 'id': '766'}, {'drugID': '1650', 'drugName': 'Meclofenamic acid', 'id': '1650'}, {'drugID': '829', 'drugName': 'Dexamethasone valerate', 'id': '829'}, {'drugID': '2475', 'drugName': 'Spironolactone', 'id': '2475'}], 'target': [{'id': '285', 'targetID': '285', 'targetName': 'AR', 'targetSpecies': 'Homo sapiens', 'targetType': 'Nuclear hormone receptor', 'uniprotID': 'P10275'}, {'id': '650', 'targetID': '650', 'targetName': 'HIF1A', 'targetSpecies': 'Homo sapiens', 'targetType': 'Transcription factor', 'uniprotID': 'Q16665'}], 'expEvidence': [{'expID': '8734', 'assayRelation': '', 'assayDescription': '', 'expSourceSet': '1', 'id': '8734'}, {'expID': '7613', 'assayType': 'Ki', 'assayValueMedian': '4.68', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': '', 'expSourceSet': '4', 'id': '7613'}, {'expID': '3049', 'assayType': 'EC50', 'assayValueMedian': '1.78E+04', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'Activation of human HIF1alpha expressed in DFX-induced human U2OS cells incubated for 30 mins prior to DFX-induction measured after overnight incubation by luciferase reporter gene assay', 'expSourceSet': '252', 'id': '3049'}, {'expID': '6029', 'assayType': 'EC50', 'assayValueMedian': '0.141', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'Agonist activity at androgen receptor (unknown origin) expressed in HeLa cells co-expressing PSA-(ARE)4-Luc13 assessed as induction of DHT-induced luciferase activity after 20 mins by luciferase reporter gene assay', 'expSourceSet': '476', 'id': '6029'}, {'expID': '5178', 'assayType': 'Ki', 'assayValueMedian': '1.29E+03', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'Binding affinity against GST-hARLBD was measured in SC-3 cell by using [3H]testosterone as radioligand', 'expSourceSet': '12', 'id': '5178'}, {'expID': '14255', 'assayType': 'Ki', 'assayValueMedian': '0.251', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'Displacement of [3H]DHT from human androgen receptor in MDA453 cells', 'expSourceSet': '12', 'id': '14255'}, {'expID': '13201', 'assayType': 'EC50', 'assayValueMedian': '0.219', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'Mechanism of Action; CHEMBL1871; SINGLE PROTEIN', 'expSourceSet': '14', 'id': '13201'}, {'expID': '4605', 'assayType': 'IC50', 'assayValueMedian': '50.1', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': '', 'expSourceSet': '4', 'id': '4605'}, {'expID': '6809', 'assayType': 'IC50', 'assayValueMedian': '3.89E+04', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'Transcriptional activity at human androgen receptor BF3 site stably transfected in eGFP-expressing human LNCAP cells after 5 days by fluorometric analysis', 'expSourceSet': '531', 'id': '6809'}, {'expID': '15482', 'assayRelation': '', 'assayDescription': 'Mechanism of Action; CHEMBL1871; SINGLE PROTEIN', 'expSourceSet': '12', 'id': '15482'}, {'expID': '7963', 'assayType': 'EC50', 'assayValueMedian': '0.316', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': '', 'expSourceSet': '1', 'id': '7963'}, {'expID': '3171', 'assayType': 'Ki', 'assayValueMedian': '1.41E+03', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'Displacement of [3H]-methyltrienolone from human androgen receptor expressed in HEK293 cells', 'expSourceSet': '266', 'id': '3171'}, {'expID': '650', 'assayType': 'IC50', 'assayValueMedian': '229', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'Binding affinity at AR', 'expSourceSet': '87', 'id': '650'}, {'expID': '4725', 'assayRelation': '', 'assayDescription': '', 'expSourceSet': '4', 'id': '4725'}, {'expID': '15576', 'assayRelation': '', 'assayDescription': 'Mechanism of Action; CHEMBL1871; SINGLE PROTEIN', 'expSourceSet': '12', 'id': '15576'}, {'expID': '10699', 'assayRelation': '', 'assayDescription': 'Mechanism of Action; CHEMBL1871; SINGLE PROTEIN', 'expSourceSet': '12', 'id': '10699'}, {'expID': '4524', 'assayType': 'IC50', 'assayValueMedian': '19.1', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'Inhibitory activity against AR', 'expSourceSet': '352', 'id': '4524'}, {'expID': '4874', 'assayType': 'IC50', 'assayValueMedian': '562', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': '', 'expSourceSet': '4', 'id': '4874'}, {'expID': '15607', 'assayType': 'EC50', 'assayValueMedian': '49.0', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'Displacement of [3H]R1881 from AR in human MDA-MB-453 cells', 'expSourceSet': '12', 'id': '15607'}, {'expID': '13664', 'assayType': 'IC50', 'assayValueMedian': '3.47E+04', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'Transcriptional activity at human androgen receptor BF3 site stably transfected in eGFP-expressing human LNCAP cells after 5 days by fluorometric analysis', 'expSourceSet': '1065', 'id': '13664'}, {'expID': '10688', 'assayType': 'Ki', 'assayValueMedian': '39.8', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'Binding affinity to human androgen receptor', 'expSourceSet': '827', 'id': '10688'}, {'expID': '6872', 'assayType': 'IC50', 'assayValueMedian': '6.46E+04', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': '', 'expSourceSet': '4', 'id': '6872'}, {'expID': '645', 'assayRelation': '', 'assayDescription': '', 'expSourceSet': '4', 'id': '645'}, {'expID': '8284', 'assayType': 'IC50', 'assayValueMedian': '8.91', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'Inhibition of 1.0 nM [3H]mibolerone binding to human androgen receptor of PC3/AR cell lysate', 'expSourceSet': '12', 'id': '8284'}, {'expID': '3182', 'assayType': 'Ki', 'assayValueMedian': '1.41E+03', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': '', 'expSourceSet': '266', 'id': '3182'}, {'expID': '11550', 'assayRelation': '', 'assayDescription': 'Mechanism of Action; CHEMBL1871; SINGLE PROTEIN', 'expSourceSet': '12', 'id': '11550'}, {'expID': '4040', 'assayType': 'IC50', 'assayValueMedian': '3.16', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': '', 'expSourceSet': '4', 'id': '4040'}, {'expID': '7962', 'assayRelation': '', 'assayDescription': 'Mechanism of Action; CHEMBL1871; SINGLE PROTEIN', 'expSourceSet': '12', 'id': '7962'}, {'expID': '8663', 'assayRelation': '', 'assayDescription': '', 'expSourceSet': '9', 'id': '8663'}, {'expID': '11762', 'assayRelation': '', 'assayDescription': '', 'expSourceSet': '4', 'id': '11762'}, {'expID': '11911', 'assayType': 'IC50', 'assayValueMedian': '60.3', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'Inhibition of HIF1alpha in human U251 cells under hypoxic condition by luciferase reporter gene assay', 'expSourceSet': '893', 'id': '11911'}, {'expID': '13861', 'assayType': 'Ki', 'assayValueMedian': '0.200', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'Displacement of [3H]DHT from human androgen receptor expressed in MDA-MB-453 cells by whole cell receptor binding assay', 'expSourceSet': '1094', 'id': '13861'}, {'expID': '9433', 'assayType': 'Ki', 'assayValueMedian': '2.51E+03', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'Displacement of [3H]-methyltrienolone from human androgen receptor expressed in HEK293 cells', 'expSourceSet': '736', 'id': '9433'}, {'expID': '4015', 'assayRelation': '', 'assayDescription': '', 'expSourceSet': '9', 'id': '4015'}, {'expID': '6885', 'assayType': 'EC50', 'assayValueMedian': '6.31', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': '', 'expSourceSet': '4', 'id': '6885'}, {'expID': '7960', 'assayRelation': '', 'assayDescription': 'Mechanism of Action', 'expSourceSet': '7', 'id': '7960'}, {'expID': '11538', 'assayType': 'EC50', 'assayValueMedian': '0.631', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': '', 'expSourceSet': '1', 'id': '11538'}, {'expID': '3190', 'assayType': 'Ki', 'assayValueMedian': '1.41E+03', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': '', 'expSourceSet': '266', 'id': '3190'}, {'expID': '2815', 'assayType': 'IC50', 'assayValueMedian': '37.0', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': '', 'expSourceSet': '217', 'id': '2815'}, {'expID': '9557', 'assayType': 'Ki', 'assayValueMedian': '8.51', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'Displacement of DHT from human androgen receptor expressed in baculovirus SF-12 cells', 'expSourceSet': '745', 'id': '9557'}, {'expID': '8409', 'assayType': 'IC50', 'assayValueMedian': '75.9', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': '', 'expSourceSet': '4', 'id': '8409'}, {'expID': '8415', 'assayType': 'IC50', 'assayValueMedian': '75.9', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': '', 'expSourceSet': '4', 'id': '8415'}, {'expID': '13194', 'assayRelation': '', 'assayDescription': 'Mechanism of Action', 'expSourceSet': '20', 'id': '13194'}, {'expID': '4662', 'assayRelation': '', 'assayDescription': 'Mechanism of Action; CHEMBL1871; SINGLE PROTEIN', 'expSourceSet': '12', 'id': '4662'}, {'expID': '2866', 'assayType': 'Ki', 'assayValueMedian': '10.0', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'Mechanism of Action; CHEMBL1871; SINGLE PROTEIN', 'expSourceSet': '14', 'id': '2866'}, {'expID': '11828', 'assayType': 'IC50', 'assayValueMedian': '4.68E+04', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': '', 'expSourceSet': '4', 'id': '11828'}, {'expID': '5043', 'assayType': 'Ki', 'assayValueMedian': '5.75', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'Displacement of [3H]DHT from human AR expressed in MDA-MB-453 cells', 'expSourceSet': '12', 'id': '5043'}, {'expID': '1148', 'assayType': 'Ki', 'assayValueMedian': '19.1', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'Inhibition of human AR', 'expSourceSet': '12', 'id': '1148'}, {'expID': '4910', 'assayType': 'IC50', 'assayValueMedian': '7.59E+04', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': '', 'expSourceSet': '4', 'id': '4910'}], 'source': [{'sourceID': '531', 'sourceDatabase': '531', 'id': '531'}, {'sourceID': '352', 'sourceDatabase': '352', 'id': '352'}, {'sourceID': '217', 'sourceDatabase': '217', 'id': '217'}, {'sourceID': '87', 'sourceDatabase': '87', 'id': '87'}, {'sourceID': '893', 'sourceDatabase': '893', 'id': '893'}, {'sourceID': '736', 'sourceDatabase': '736', 'id': '736'}, {'sourceID': '20', 'sourceDatabase': '20', 'id': '20'}, {'sourceID': '1065', 'sourceDatabase': '1065', 'id': '1065'}, {'sourceID': '827', 'sourceDatabase': '827', 'id': '827'}, {'sourceID': '266', 'sourceDatabase': '266', 'id': '266'}, {'sourceID': '252', 'sourceDatabase': '252', 'id': '252'}, {'sourceID': '1094', 'sourceDatabase': '1094', 'id': '1094'}, {'sourceID': '9', 'sourceDatabase': '9', 'id': '9'}, {'sourceID': '476', 'sourceDatabase': '476', 'id': '476'}, {'sourceID': '1331', 'sourceDatabase': '0', 'id': '1331'}, {'sourceID': '745', 'sourceDatabase': '745', 'id': '745'}, {'sourceID': '7', 'sourceDatabase': '7', 'id': '7'}, {'sourceID': '1', 'sourceDatabase': '1', 'id': '1'}, {'sourceID': '4', 'sourceDatabase': '4', 'id': '4'}, {'sourceID': '12', 'sourceDatabase': '12', 'id': '12'}, {'sourceID': '14', 'sourceDatabase': '14', 'id': '14'}], 'database': [{'databaseID': '531', 'databaseName': 'CHEMBL', 'downloadURL': 'https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL52', 'id': '531'}, {'databaseID': '9', 'databaseName': 'DRUGBANK', 'downloadURL': 'https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1367478', 'id': '9'}, {'databaseID': '476', 'databaseName': 'CHEMBL', 'downloadURL': 'https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6', 'id': '476'}, {'databaseID': '1', 'databaseName': 'WOMBAT-PK', 'downloadURL': 'https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200749', 'id': '1'}, {'databaseID': '1094', 'databaseName': 'CHEMBL', 'downloadURL': 'https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL27769', 'id': '1094'}, {'databaseID': '4', 'databaseName': 'WOMBAT-PK', 'id': '4'}, {'databaseID': '352', 'databaseName': 'CHEMBL', 'downloadURL': 'https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL135', 'id': '352'}, {'databaseID': '827', 'databaseName': 'CHEMBL', 'downloadURL': 'https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1393', 'id': '827'}, {'databaseID': '266', 'databaseName': 'CHEMBL', 'downloadURL': 'https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL384467', 'id': '266'}, {'databaseID': '252', 'databaseName': 'CHEMBL', 'downloadURL': 'https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL556', 'id': '252'}, {'databaseID': '14', 'databaseName': 'IUPHAR', 'downloadURL': 'http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1188', 'id': '14'}, {'databaseID': '20', 'databaseName': 'KEGG DRUG', 'downloadURL': 'http://www.kegg.jp/entry/D01582', 'id': '20'}, {'databaseID': '0', 'databaseName': 'DrugCentral', 'id': '0'}, {'databaseID': '12', 'databaseName': 'CHEMBL', 'downloadURL': 'https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1489', 'id': '12'}, {'databaseID': '217', 'databaseName': 'WOMBAT-PK', 'downloadURL': 'http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2398', 'id': '217'}, {'databaseID': '893', 'databaseName': 'CHEMBL', 'downloadURL': 'https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL84', 'id': '893'}, {'databaseID': '1065', 'databaseName': 'CHEMBL', 'downloadURL': 'https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL41632', 'id': '1065'}, {'databaseID': '745', 'databaseName': 'CHEMBL', 'downloadURL': 'https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL103', 'id': '745'}, {'databaseID': '87', 'databaseName': 'CHEMBL', 'downloadURL': 'https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL440283', 'id': '87'}, {'databaseID': '736', 'databaseName': 'CHEMBL', 'downloadURL': 'https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL131', 'id': '736'}, {'databaseID': '7', 'databaseName': 'IUPHAR', 'downloadURL': 'http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2334', 'id': '7'}]}, {'interaction': [{'interactionID': '1216', 'drug': '511', 'target': '420', 'interactionType': '', 'source': '1331', 'expEvidence': '1611', 'id': '1216'}, {'interactionID': '10402', 'drug': '3514', 'target': '1038', 'interactionType': '', 'source': '1331', 'expEvidence': '13332', 'id': '10402'}, {'interactionID': '2844', 'drug': '928', 'target': '420', 'interactionType': '', 'source': '1331', 'expEvidence': '3748', 'id': '2844'}, {'interactionID': '13260', 'drug': '5039', 'target': '420', 'interactionType': '', 'source': '1331', 'expEvidence': '16519', 'id': '13260'}, {'interactionID': '10915', 'drug': '4063', 'target': '420', 'interactionType': '', 'source': '1331', 'expEvidence': '13940', 'id': '10915'}, {'interactionID': '12325', 'drug': '4392', 'target': '420', 'interactionType': '', 'source': '1331', 'expEvidence': '15404', 'id': '12325'}, {'interactionID': '6304', 'drug': '1912', 'target': '1038', 'interactionType': '', 'source': '1331', 'expEvidence': '8093', 'id': '6304'}, {'interactionID': '9073', 'drug': '2632', 'target': '420', 'interactionType': '', 'source': '1331', 'expEvidence': '11638', 'id': '9073'}, {'interactionID': '9823', 'drug': '2855', 'target': '420', 'interactionType': '', 'source': '1331', 'expEvidence': '12580', 'id': '9823'}, {'interactionID': '4690', 'drug': '1457', 'target': '420', 'interactionType': '', 'source': '1331', 'expEvidence': '6068', 'id': '4690'}, {'interactionID': '11593', 'drug': '4189', 'target': '420', 'interactionType': '', 'source': '1331', 'expEvidence': '14631', 'id': '11593'}, {'interactionID': '6007', 'drug': '1810', 'target': '1038', 'interactionType': '', 'source': '1331', 'expEvidence': '7664', 'id': '6007'}, {'interactionID': '8286', 'drug': '2459', 'target': '420', 'interactionType': '', 'source': '1331', 'expEvidence': '10620', 'id': '8286'}, {'interactionID': '12619', 'drug': '4733', 'target': '420', 'interactionType': '', 'source': '1331', 'expEvidence': '15798', 'id': '12619'}, {'interactionID': '6270', 'drug': '1893', 'target': '420', 'interactionType': '', 'source': '1331', 'expEvidence': '8026', 'id': '6270'}, {'interactionID': '4399', 'drug': '1364', 'target': '420', 'interactionType': '', 'source': '1331', 'expEvidence': '5658', 'id': '4399'}], 'drug': [{'drugID': '2459', 'drugName': 'Sorafenib', 'id': '2459'}, {'drugID': '3514', 'drugName': 'Quercetin', 'id': '3514'}, {'drugID': '2632', 'drugName': 'Thioguanine', 'id': '2632'}, {'drugID': '1457', 'drugName': 'Diiodohydroxyquinoline', 'id': '1457'}, {'drugID': '511', 'drugName': 'Carmofur', 'id': '511'}, {'drugID': '1912', 'drugName': 'Niclosamide', 'id': '1912'}, {'drugID': '1893', 'drugName': 'Nelfinavir', 'id': '1893'}, {'drugID': '1810', 'drugName': 'Miltefosine', 'id': '1810'}, {'drugID': '928', 'drugName': 'Disulfiram', 'id': '928'}, {'drugID': '4733', 'drugName': 'Thiomersal', 'id': '4733'}, {'drugID': '4063', 'drugName': 'Tirilazad', 'id': '4063'}, {'drugID': '2855', 'drugName': 'Zafirlukast', 'id': '2855'}, {'drugID': '1364', 'drugName': 'Hexachlorophene', 'id': '1364'}, {'drugID': '4392', 'drugName': 'Cisplatin', 'id': '4392'}, {'drugID': '5039', 'drugName': 'Tannic acid', 'id': '5039'}, {'drugID': '4189', 'drugName': 'Hydroxyprogesterone caproate', 'id': '4189'}], 'target': [{'id': '1038', 'targetID': '1038', 'targetName': 'AKT1', 'targetSpecies': 'Homo sapiens', 'targetType': 'Kinase', 'uniprotID': 'P31749'}, {'id': '420', 'targetID': '420', 'targetName': 'MAPK3', 'targetSpecies': 'Homo sapiens', 'targetType': 'Kinase', 'uniprotID': 'P27361'}], 'expEvidence': [{'expID': '16519', 'assayType': 'IC50', 'assayValueMedian': '4.07E+03', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'DRUGMATRIX: Protein Serine/Threonine Kinase, ERK1 enzyme inhibition (substrate: Myelin Basic Protein)', 'expSourceSet': '1306', 'id': '16519'}, {'expID': '14631', 'assayType': 'IC50', 'assayValueMedian': '3.16E+03', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'DRUGMATRIX: Protein Serine/Threonine Kinase, ERK1 enzyme inhibition (substrate: Myelin Basic Protein)', 'expSourceSet': '2', 'id': '14631'}, {'expID': '8026', 'assayType': 'IC50', 'assayValueMedian': '2.25E+04', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'DRUGMATRIX: Protein Serine/Threonine Kinase, ERK1 enzyme inhibition (substrate: Myelin Basic Protein)', 'expSourceSet': '2', 'id': '8026'}, {'expID': '7664', 'assayType': 'IC50', 'assayValueMedian': '9.55E+03', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'Inhibition of Akt phosphorylation in human insulin-stimulated A549 cells incubated for 2 hrs prior to insulin-induction measured after 30 mins by ELISA', 'expSourceSet': '595', 'id': '7664'}, {'expID': '13332', 'assayType': 'IC50', 'assayValueMedian': '5.37E+03', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'Inhibition of AKT1 (unknown origin)', 'expSourceSet': '1045', 'id': '13332'}, {'expID': '10620', 'assayType': 'IC50', 'assayValueMedian': '18.2', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': '', 'expSourceSet': '823', 'id': '10620'}, {'expID': '12580', 'assayType': 'IC50', 'assayValueMedian': '4.38E+03', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'DRUGMATRIX: Protein Serine/Threonine Kinase, ERK1 enzyme inhibition (substrate: Myelin Basic Protein)', 'expSourceSet': '2', 'id': '12580'}, {'expID': '8093', 'assayType': 'IC50', 'assayValueMedian': '5.89E+04', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'Inhibition of Akt1 after 60 mins by radiometric assay', 'expSourceSet': '633', 'id': '8093'}, {'expID': '11638', 'assayType': 'IC50', 'assayValueMedian': '5.52E+03', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'DRUGMATRIX: Protein Serine/Threonine Kinase, ERK1 enzyme inhibition (substrate: Myelin Basic Protein)', 'expSourceSet': '2', 'id': '11638'}, {'expID': '3748', 'assayType': 'IC50', 'assayValueMedian': '1.51E+03', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'DRUGMATRIX: Protein Serine/Threonine Kinase, ERK1 enzyme inhibition (substrate: Myelin Basic Protein)', 'expSourceSet': '2', 'id': '3748'}, {'expID': '13940', 'assayType': 'IC50', 'assayValueMedian': '1.63E+04', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'DRUGMATRIX: Protein Serine/Threonine Kinase, ERK1 enzyme inhibition (substrate: Myelin Basic Protein)', 'expSourceSet': '2', 'id': '13940'}, {'expID': '15404', 'assayType': 'IC50', 'assayValueMedian': '4.62E+03', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'DRUGMATRIX: Protein Serine/Threonine Kinase, ERK1 enzyme inhibition (substrate: Myelin Basic Protein)', 'expSourceSet': '2', 'id': '15404'}, {'expID': '1611', 'assayType': 'IC50', 'assayValueMedian': '6.12E+03', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'DRUGMATRIX: Protein Serine/Threonine Kinase, ERK1 enzyme inhibition (substrate: Myelin Basic Protein)', 'expSourceSet': '2', 'id': '1611'}, {'expID': '5658', 'assayType': 'IC50', 'assayValueMedian': '2.48E+03', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'DRUGMATRIX: Protein Serine/Threonine Kinase, ERK1 enzyme inhibition (substrate: Myelin Basic Protein)', 'expSourceSet': '2', 'id': '5658'}, {'expID': '15798', 'assayType': 'IC50', 'assayValueMedian': '774', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'DRUGMATRIX: Protein Serine/Threonine Kinase, ERK1 enzyme inhibition (substrate: Myelin Basic Protein)', 'expSourceSet': '2', 'id': '15798'}, {'expID': '6068', 'assayType': 'IC50', 'assayValueMedian': '5.26E+03', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'DRUGMATRIX: Protein Serine/Threonine Kinase, ERK1 enzyme inhibition (substrate: Myelin Basic Protein)', 'expSourceSet': '2', 'id': '6068'}], 'source': [{'sourceID': '595', 'sourceDatabase': '595', 'id': '595'}, {'sourceID': '633', 'sourceDatabase': '633', 'id': '633'}, {'sourceID': '1306', 'sourceDatabase': '1306', 'id': '1306'}, {'sourceID': '823', 'sourceDatabase': '823', 'id': '823'}, {'sourceID': '1045', 'sourceDatabase': '1045', 'id': '1045'}, {'sourceID': '2', 'sourceDatabase': '2', 'id': '2'}, {'sourceID': '1331', 'sourceDatabase': '0', 'id': '1331'}], 'database': [{'databaseID': '595', 'databaseName': 'CHEMBL', 'downloadURL': 'https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL125', 'id': '595'}, {'databaseID': '1306', 'databaseName': 'CHEMBL', 'downloadURL': 'https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL506247', 'id': '1306'}, {'databaseID': '2', 'databaseName': 'DRUG MATRIX', 'id': '2'}, {'databaseID': '1045', 'databaseName': 'CHEMBL', 'downloadURL': 'https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50', 'id': '1045'}, {'databaseID': '633', 'databaseName': 'CHEMBL', 'downloadURL': 'https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1448', 'id': '633'}, {'databaseID': '823', 'databaseName': 'CHEMBL', 'downloadURL': 'https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336', 'id': '823'}, {'databaseID': '0', 'databaseName': 'DrugCentral', 'id': '0'}]}, {'interaction': [{'interactionID': '12648', 'drug': '4778', 'target': '535', 'interactionType': 'INHIBITOR', 'source': '1331', 'expEvidence': '15832', 'id': '12648'}, {'interactionID': '3603', 'drug': '1118', 'target': '535', 'interactionType': 'INHIBITOR', 'source': '1331', 'expEvidence': '4722', 'id': '3603'}, {'interactionID': '2464', 'drug': '849', 'target': '660', 'interactionType': '', 'source': '1331', 'expEvidence': '3281', 'id': '2464'}, {'interactionID': '2113', 'drug': '785', 'target': '535', 'interactionType': '', 'source': '1331', 'expEvidence': '2904', 'id': '2113'}, {'interactionID': '11218', 'drug': '4161', 'target': '535', 'interactionType': '', 'source': '1331', 'expEvidence': '14278', 'id': '11218'}, {'interactionID': '8778', 'drug': '2552', 'target': '535', 'interactionType': '', 'source': '1331', 'expEvidence': '11274', 'id': '8778'}, {'interactionID': '8152', 'drug': '2446', 'target': '535', 'interactionType': '', 'source': '1331', 'expEvidence': '10475', 'id': '8152'}, {'interactionID': '242', 'drug': '136', 'target': '185', 'interactionType': '', 'source': '1331', 'expEvidence': '338', 'id': '242'}], 'drug': [{'drugID': '2446', 'drugName': 'Sirolimus', 'id': '2446'}, {'drugID': '4161', 'drugName': 'Temsirolimus', 'id': '4161'}, {'drugID': '2552', 'drugName': 'Tacrolimus', 'id': '2552'}, {'drugID': '4778', 'drugName': 'Ridaforolimus', 'id': '4778'}, {'drugID': '849', 'drugName': 'Diacerein', 'id': '849'}, {'drugID': '136', 'drugName': 'Alprazolam', 'id': '136'}, {'drugID': '785', 'drugName': 'Dasatinib', 'id': '785'}, {'drugID': '1118', 'drugName': 'Everolimus', 'id': '1118'}], 'target': [{'id': '660', 'targetID': '660', 'targetName': 'CASP3', 'targetSpecies': 'Homo sapiens', 'targetType': 'Enzyme', 'uniprotID': 'P42574'}, {'id': '185', 'targetID': '185', 'targetName': 'BRD4', 'targetSpecies': 'Homo sapiens', 'targetType': 'Unclassified', 'uniprotID': 'O60885'}, {'id': '535', 'targetID': '535', 'targetName': 'MTOR', 'targetSpecies': 'Homo sapiens', 'targetType': 'Kinase', 'uniprotID': 'P42345'}], 'expEvidence': [{'expID': '2904', 'assayType': 'IC50', 'assayValueMedian': '3.47E+04', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'Inhibition of recombinant mTOR by radioactive phosphotransfer assay in presence of 10 uM ATP', 'expSourceSet': '249', 'id': '2904'}, {'expID': '15832', 'assayType': 'IC50', 'assayValueMedian': '0.200', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'Measured as dose-dependent inhibition of phosphorylation of ribosomal protein S6, a signaling protein downstream of mTOR', 'expSourceSet': '8', 'id': '15832'}, {'expID': '10475', 'assayType': 'IC50', 'assayValueMedian': '0.100', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'Inhibition of mTOR kinase expressed in human HEK293 cells by Western blot analysis', 'expSourceSet': '817', 'id': '10475'}, {'expID': '338', 'assayType': 'Kd', 'assayValueMedian': '2.45E+03', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'Binding affinity to BRD4-BD1 by isothermal titration calorimetry', 'expSourceSet': '57', 'id': '338'}, {'expID': '11274', 'assayType': 'IC50', 'assayValueMedian': '0.955', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'Inhibitory activity against macrophilin (FKBP-12)', 'expSourceSet': '849', 'id': '11274'}, {'expID': '3281', 'assayType': 'EC50', 'assayValueMedian': '7.94E+03', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'PUBCHEM_BIOASSAY: Absorbance-based biochemical high throughput dose response assay for activators of procaspase-3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463141, AID463197, AID463210, AID488941, AID488954, AID493114, AID493115, AID504328, AID504330]', 'expSourceSet': '271', 'id': '3281'}, {'expID': '14278', 'assayType': 'IC50', 'assayValueMedian': '1.78E+03', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': 'Inhibition of FKBP12-independent human recombinant mTOR expressed in HEK293 cells using His6-S6K1 as a substrate by DELFIA assay', 'expSourceSet': '1128', 'id': '14278'}, {'expID': '4722', 'assayType': 'IC50', 'assayValueMedian': '2.00', 'assayUnits': 'nM', 'assayRelation': '=', 'assayDescription': '', 'expSourceSet': '368', 'id': '4722'}], 'literature': {'literatureID': '8', 'PubMedID': '17276408', 'id': '8', 'litID': '8', 'pubMedID': '17276408'}, 'source': [{'sourceID': '57', 'sourceDatabase': '57', 'id': '57'}, {'sourceID': '1128', 'sourceDatabase': '1128', 'id': '1128'}, {'sourceID': '8', 'sourceLiterature': '8', 'sourceDatabase': '0', 'id': '8'}, {'sourceID': '817', 'sourceDatabase': '817', 'id': '817'}, {'sourceID': '271', 'sourceDatabase': '271', 'id': '271'}, {'sourceID': '368', 'sourceDatabase': '368', 'id': '368'}, {'sourceID': '1331', 'sourceDatabase': '0', 'id': '1331'}, {'sourceID': '249', 'sourceDatabase': '249', 'id': '249'}, {'sourceID': '849', 'sourceDatabase': '849', 'id': '849'}], 'database': [{'databaseID': '817', 'databaseName': 'CHEMBL', 'downloadURL': 'https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL413', 'id': '817'}, {'databaseID': '368', 'databaseName': 'IUPHAR', 'downloadURL': 'http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5889', 'id': '368'}, {'databaseID': '57', 'databaseName': 'CHEMBL', 'downloadURL': 'https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL661', 'id': '57'}, {'databaseID': '249', 'databaseName': 'CHEMBL', 'downloadURL': 'https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421', 'id': '249'}, {'databaseID': '1128', 'databaseName': 'CHEMBL', 'downloadURL': 'https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201182', 'id': '1128'}, {'databaseID': '849', 'databaseName': 'CHEMBL', 'downloadURL': 'https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL269732', 'id': '849'}, {'databaseID': '271', 'databaseName': 'CHEMBL', 'downloadURL': 'https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL41286', 'id': '271'}, {'databaseID': '0', 'databaseName': 'DrugCentral', 'id': '0'}]}]\n"
     ]
    }
   ],
   "source": [
    "result_drug_targets = [fiviz.genelist_drug_target(ids=\",\".join(d), source=\"drugcentral\") for d in img_dict.values()]\n",
    "print(result_drug_targets)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "outputs": [],
   "source": [],
   "metadata": {
    "collapsed": false,
    "pycharm": {
     "name": "#%%\n"
    }
   }
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.3"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}